2007 ESH‐ESC Guidelines for the management of arterial hypertension

Authors/Task Force Members: Giuseppe Mancia, Co-Chairperson (Italy), Guy De Backer, Co-Chairperson (Belgium), Anna Dominiczak (UK), Renata Cifkova (Czech Republic) Robert Fagard (Belgium), Giuseppe Germano (Italy), Guido Grassi (Italy), Anthony M. Heagerty (UK), Sverre E. Kjeldsen (Norway), Stephane Laurent (France), Krzysztof Narkiewicz (Poland), Luis Ruilope (Spain), Andrzej Rynkiewicz (Poland), Roland E. Schmieder (Germany), Harry A.J. Struijker Boudier (Netherlands), Alberto Zanchetti (Italy)

[1]  B. Sibbald,et al.  Effects of pay for performance on the quality of primary care in England. , 2009, The New England journal of medicine.

[2]  L. Djoussé,et al.  Normal systolic blood pressure and risk of heart failure in US male physicians , 2009, European journal of heart failure.

[3]  Stephan Willems,et al.  Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. , 2009, European heart journal.

[4]  R. Klein,et al.  Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. , 2009, American journal of epidemiology.

[5]  G. Lip,et al.  Improving survival of malignant hypertension patients over 40 years. , 2009, American journal of hypertension.

[6]  G. Mancia,et al.  INVEST revisited: review of findings from the International Verapamil SR–Trandolapril Study , 2009, Expert review of cardiovascular therapy.

[7]  S. Rubin,et al.  Exercise hypertension: an adverse prognosis? , 2009, Journal of the American Society of Hypertension : JASH.

[8]  L. Ghiadoni,et al.  Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease , 2009, Diabetes Care.

[9]  Shimin Zheng,et al.  The potency of team-based care interventions for hypertension: a meta-analysis. , 2009, Archives of internal medicine.

[10]  B. Wiens,et al.  A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.

[11]  Alessandro Filippi,et al.  Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients , 2009, Circulation.

[12]  D. Schlessinger,et al.  Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[13]  K. Kario,et al.  Differential Effects Between a Calcium Channel Blocker and a Diuretic When Used in Combination With Angiotensin II Receptor Blocker on Central Aortic Pressure in Hypertensive Patients , 2009, Hypertension.

[14]  S. Oparil,et al.  Effects of Dietary Sodium Reduction on Blood Pressure in Subjects With Resistant Hypertension: Results From a Randomized Trial , 2009, Hypertension.

[15]  J. Staessen,et al.  Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial , 2009, The Lancet.

[16]  G. Mancia,et al.  Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension , 2009, Journal of hypertension.

[17]  A. Zanchetti.  Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced? , 2009, Journal of hypertension.

[18]  Mark Woodward,et al.  Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. , 2009, Journal of the American Society of Nephrology : JASN.

[19]  V. Salomaa,et al.  Prevalence, awareness and treatment of hypertension in Finland during 1982–2007 , 2009, Journal of hypertension.

[20]  N. Kaplan.  Prehypertension: is it relevant for nephrologists? , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[21]  Qian-Li Xue,et al.  Change in Blood Pressure and Incident Dementia: A 32-Year Prospective Study , 2009, Hypertension.

[22]  G. Mancia,et al.  Long-Term Risk of Sustained Hypertension in White-Coat or Masked Hypertension , 2009, Hypertension.

[23]  A. Hughes,et al.  Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial , 2009, Diabetologia.

[24]  M. I. Perez,et al.  Treatment blood pressure targets for hypertension. , 2009, The Cochrane database of systematic reviews.

[25]  A. Da Silva,et al.  Beta blockers for peripheral arterial disease. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[26]  D. Belletti,et al.  A narrative review of clinical inertia: focus on hypertension. , 2009, Journal of the American Society of Hypertension : JASH.

[27]  S. Yusuf,et al.  Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study , 2009, Journal of hypertension.

[28]  P. Gargiulo,et al.  Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175 634 patients , 2009, Journal of hypertension.

[29]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[30]  N. Sattar,et al.  Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials , 2009, The Lancet.

[31]  N J Wald,et al.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.

[32]  G. Mancia,et al.  When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal , 2009, Journal of hypertension.

[33]  N. Lunet,et al.  Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries , 2009, Journal of hypertension.

[34]  N. Poulter,et al.  Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension , 2009, Journal of hypertension.

[35]  J. Engvall,et al.  Masked nocturnal hypertension—a novel marker of risk in type 2 diabetes , 2009, Diabetologia.

[36]  M. Nieminen,et al.  Prognostic Value of Changes in the Electrocardiographic Strain Pattern During Antihypertensive Treatment: The Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE) , 2009, Circulation.

[37]  Sonia S Anand,et al.  A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. , 2009, Archives of internal medicine.

[38]  Krzysztof Bartus,et al.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study , 2009, The Lancet.

[39]  P. Hofman,et al.  Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients , 2009, Journal of hypertension.

[40]  T. LeCompte,et al.  Vascular Structure and Function Is Correlated to Cognitive Performance and White Matter Hyperintensities in Older Hypertensive Patients With Subjective Memory Complaints , 2009, Stroke.

[41]  P. Hedberg,et al.  Augmented blood pressure response to exercise is associated with improved long-term survival in older people , 2009, Heart.

[42]  K. Kotseva,et al.  Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries , 2009, The Lancet.

[43]  J. Staessen,et al.  Night–day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension , 2009, Journal of Human Hypertension.

[44]  F. Paccaud,et al.  Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[45]  Carol Jagger,et al.  Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial , 2009, The Lancet Neurology.

[46]  C. N. Bairey Merz,et al.  Contraceptive hormone use and cardiovascular disease. , 2009, Journal of the American College of Cardiology.

[47]  Grant D. Huang,et al.  Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.

[48]  R. Fahlbusch,et al.  Temporary Reduction of Blood Pressure and Sympathetic Nerve Activity in Hypertensive Patients After Microvascular Decompression , 2009, Stroke.

[49]  Jens-Uwe Voigt,et al.  Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). , 2008, European heart journal.

[50]  C. Erem,et al.  Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study. , 2008, Journal of public health.

[51]  F. Flachskampf,et al.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[52]  R. Beech,et al.  Service developments for managing people with long-term conditions using case management approaches, an example from the UK , 2008, International journal of integrated care.

[53]  R. Garrick.  Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease , 2009 .

[54]  D. Schteingart.  Vascular Remodeling and Duration of Hypertension Predict Outcome of Adrenalectomy in Primary Aldosteronism Patients , 2009 .

[55]  R. West,et al.  Relapse prevention interventions for smoking cessation. , 2009, The Cochrane database of systematic reviews.

[56]  Yanxing Zhao,et al.  Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension. , 2009, Current medical research and opinion.

[57]  The Control Group.  Intensive glucose control and macrovascular outcomes in type 2 diabetes , 2009, Diabetologia.

[58]  Susan Anderson,et al.  Irbesartan in patients with heart failure and preserved ejection fraction. , 2008, The New England journal of medicine.

[59]  G. Bakris,et al.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.

[60]  J. Staessen,et al.  Prognostic significance of ambulatory blood pressure in hypertensive patients with history of cardiovascular disease , 2008, Blood pressure monitoring.

[61]  F. Cappuccio,et al.  Prevalence, awareness, treatment and control of hypertension in healthy unrelated male–female pairs of European regions: the dietary habit profile in European communities with different risk of myocardial infarction – the impact of migration as a model of gene–environment interaction project , 2008, Journal of hypertension.

[62]  石井當男.  Principal Results of the Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS) , 2008, Hypertension Research.

[63]  L. Appel,et al.  Changes in Serum Potassium Mediate Thiazide-Induced Diabetes , 2008, Hypertension.

[64]  K. Asayama,et al.  Day-by-Day Variability of Blood Pressure and Heart Rate at Home as a Novel Predictor of Prognosis: The Ohasama Study , 2008, Hypertension.

[65]  N. Donner‐Banzhoff,et al.  Statins and primary prevention of cardiovascular events , 2008, BMJ : British Medical Journal.

[66]  A. Manolis,et al.  Sexual dysfunction: the ‘prima ballerina’ of hypertension-related quality-of-life complications , 2008, Journal of hypertension.

[67]  S. Yusuf,et al.  Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. , 2008, American heart journal.

[68]  M. Morgan,et al.  Effect of social deprivation on blood pressure monitoring and control in England: a survey of data from the quality and outcomes framework , 2008, BMJ : British Medical Journal.

[69]  N. Paynter,et al.  C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men , 2008, Circulation.

[70]  R. Klein,et al.  Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials , 2008, The Lancet.

[71]  S. Yusuf,et al.  Telmisartan to prevent recurrent stroke and cardiovascular events. , 2008, The New England journal of medicine.

[72]  G. Grassi,et al.  BLOOD PRESSURE RESPONSE TO ACUTE PHYSICAL AND MENTAL STRESS , 2008 .

[73]  Pierre-François Plouin,et al.  Masked hypertension: a systematic review. , 2008, Journal of hypertension.

[74]  V. Froelicher,et al.  The blood pressure response to dynamic exercise testing: a systematic review. , 2008, Progress in cardiovascular diseases.

[75]  W. Young,et al.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[76]  S. Yusuf,et al.  Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial , 2008, The Lancet.

[77]  Yutaka Imai,et al.  European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring , 2008, Journal of hypertension.

[78]  C. Bulpitt,et al.  Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial , 2008, The Lancet Neurology.

[79]  E. Ferenczi,et al.  Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure , 2008, Heart.

[80]  B. Pannier,et al.  All-cause and cardiovascular mortality using the different definitions of metabolic syndrome. , 2008, The American journal of cardiology.

[81]  A Hofman,et al.  Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. , 2008, JAMA.

[82]  M. Volpe,et al.  Development of heart failure in recent hypertension trials , 2008, Journal of hypertension.

[83]  G. Mancia,et al.  Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis , 2008, Journal of hypertension.

[84]  Fabian Bamberg,et al.  Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis , 2008, Journal of hypertension.

[85]  M. Böhm,et al.  The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure – a prospective, randomized, controlled prevention trial of the German Hypertension League , 2008, Journal of hypertension.

[86]  N. Chapman,et al.  Effect of Doxazosin Gastrointestinal Therapeutic System as Third-Line Antihypertensive Therapy on Blood Pressure and Lipids in the Anglo-Scandinavian Cardiac Outcomes Trial , 2008, Circulation.

[87]  A. Sheikh,et al.  Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 , 2008, BMJ : British Medical Journal.

[88]  S. Oparil,et al.  Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. , 2008, Archives of internal medicine.

[89]  E. Lewis,et al.  Aliskiren combined with losartan in type 2 diabetes and nephropathy. , 2008, The New England journal of medicine.

[90]  D. Singer,et al.  Management of hypertension in peripheral arterial disease: does the choice of drugs matter? , 2008, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[91]  G. Viberti,et al.  Valsartan Improves Arterial Stiffness in Type 2 Diabetes Independently of Blood Pressure Lowering , 2008, Hypertension.

[92]  John Urquhart,et al.  Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories , 2008, BMJ : British Medical Journal.

[93]  Cong Sun,et al.  Retinal vascular caliber, blood pressure, and cardiovascular risk factors in an Asian population: the Singapore Malay Eye Study. , 2008, Investigative ophthalmology & visual science.

[94]  Li-sheng Liu,et al.  Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.

[95]  S. Yusuf,et al.  Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[96]  G. Mancia,et al.  Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy , 2008, Journal of Hypertension.

[97]  A. Zanchetti,et al.  Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial , 2008, Journal of hypertension.

[98]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[99]  G. Mancia,et al.  Choice of antihypertensive drugs in the European Society of Hypertension-European Society of Cardiology guidelines: specific indications rather than ranking for general usage. , 2008, Journal of hypertension.

[100]  Yasmin,et al.  A comparison of atenolol and nebivolol in isolated systolic hypertension , 2008, Journal of hypertension.

[101]  Jan A. Staessen,et al.  Daytime and Nighttime Blood Pressure as Predictors of Death and Cause-Specific Cardiovascular Events in Hypertension , 2008, Hypertension.

[102]  B. Thiers.  Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis , 2008 .

[103]  W. Elliott.  Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study , 2008 .

[104]  M. D. De Buyzere,et al.  Management of hypertension in peripheral arterial disease. , 2008, Progress in cardiovascular diseases.

[105]  Yikyung Park,et al.  Physical activity recommendations and decreased risk of mortality. , 2007, Archives of internal medicine.

[106]  J. Myers,et al.  Prognostic significance of systolic blood pressure increases in men during exercise stress testing. , 2007, The American journal of cardiology.

[107]  D. Brunenberg,et al.  Self-Measurement of Blood Pressure at Home Reduces the Need for Antihypertensive Drugs: A Randomized, Controlled Trial , 2007, Hypertension.

[108]  A. Pose-Reino,et al.  [Should beta-blockers remain first choice in the treatment of primary hypertension?]. , 2007, Medicina clinica.

[109]  R. Fagard,et al.  Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis , 2007, Journal of hypertension.

[110]  J. McMurray,et al.  Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure , 2007, European journal of heart failure.

[111]  A. Hingorani,et al.  Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[112]  Yan Li,et al.  Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study , 2007, The Lancet.

[113]  C. Bulpitt,et al.  On-treatment diastolic blood pressure and prognosis in systolic hypertension. , 2007, Archives of internal medicine.

[114]  Bruce Guthrie,et al.  Tackling therapeutic inertia: role of treatment data in quality indicators , 2007, BMJ : British Medical Journal.

[115]  Anushka Patel,et al.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial , 2007, The Lancet.

[116]  A. Tveit,et al.  Candesartan in the prevention of relapsing atrial fibrillation. , 2007, International journal of cardiology.

[117]  H. Adami,et al.  A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women. , 2007, Fertility and sterility.

[118]  J. Gaziano,et al.  Effect of treating erectile dysfunction on management of systolic hypertension. , 2007, The American journal of cardiology.

[119]  G. Mancia,et al.  Blood Pressure Control and Improved Cardiovascular Outcomes in the International Verapamil SR-Trandolapril Study , 2007, Hypertension.

[120]  K. Reynolds,et al.  Effect of Nocturnal Nasal Continuous Positive Airway Pressure on Blood Pressure in Obstructive Sleep Apnea , 2007, Hypertension.

[121]  T. Simon,et al.  [Management of cardiovascular risk in the peri-menopausal woman--a consensus statement of European cardiologists and gynaecologists]. , 2007, Kardiologia polska.

[122]  P. Koudstaal,et al.  Silent brain infarcts: a systematic review , 2007, The Lancet Neurology.

[123]  M. Aguilar,et al.  Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.

[124]  Piotr Ponikowski,et al.  2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.

[125]  L. Wilhelmsen,et al.  Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up , 2007, Journal of hypertension.

[126]  G. Mancia,et al.  Long-Term Prognostic Value of Blood Pressure Variability in the General Population: Results of the Pressioni Arteriose Monitorate e Loro Associazioni Study , 2007, Hypertension.

[127]  T. Zeller.  Renal artery stenosis , 2007, Current treatment options in cardiovascular medicine.

[128]  Quan-ying He,et al.  [Effect of long-term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnea hypopnea syndrome: a meta-analysis of clinical trials]. , 2007, Zhonghua yi xue za zhi.

[129]  G. Mancia,et al.  The sympathetic nervous system and the metabolic syndrome. , 2007, Journal of hypertension.

[130]  M. Pfeffer,et al.  Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system , 2007, Journal of hypertension.

[131]  G. Jennings,et al.  Left ventricular hypertrophy: beyond the image and defining the human cardiac phenotype in hypertension , 2007, Journal of hypertension.

[132]  Giuseppe Mancia,et al.  Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis , 2007, Journal of hypertension.

[133]  D. Rizzoni,et al.  Inappropriate Left Ventricular Mass Changes During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients , 2007, Hypertension.

[134]  N. Tajima,et al.  RETRACTED: Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study , 2007, The Lancet.

[135]  A. Dupont,et al.  The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. , 2007, Archives of internal medicine.

[136]  N. Cook,et al.  Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) , 2007, BMJ : British Medical Journal.

[137]  R. Schmieder,et al.  Renin-angiotensin system and cardiovascular risk , 2007, The Lancet.

[138]  F. Zannad.  Aldosterone antagonist therapy in resistant hypertension , 2007, Journal of hypertension.

[139]  D. Lane,et al.  Low-dose spironolactone in the management of resistant hypertension: a surveillance study , 2007, Journal of hypertension.

[140]  R. Cooper.  Using public health indicators to measure the success of hypertension control. , 2007, Hypertension.

[141]  G. Bakris.  Differences in Glucose Tolerance Between Fixed-Dose Antihypertensive Drug Combinations in People With Metabolic Syndrome , 2007, Diabetes Care.

[142]  J. Redón,et al.  Differences in Blood Pressure Control and Stroke Mortality Across Spain: The Prevención de Riesgo de Ictus (PREV-ICTUS) Study , 2007, Hypertension.

[143]  M. Fisher,et al.  Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) , 2007 .

[144]  K. Greenlund,et al.  Blood pressure parameters and risk of fatal stroke, NHANES II mortality study. , 2007, American journal of hypertension.

[145]  M. Mattarello,et al.  Detecting and Treating Primary Aldosteronism , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[146]  G. Lip,et al.  Effect of hypertension on anticoagulated patients with atrial fibrillation. , 2007, European heart journal.

[147]  J. Staessen,et al.  Less Atherosclerosis and Lower Blood Pressure for a Meaningful Life Perspective With More Brain , 2007, Hypertension.

[148]  J. Le Heuzey,et al.  Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis. , 2007, European heart journal.

[149]  M. Walsh,et al.  Low rate of sex-specific result reporting in cardiovascular trials. , 2007, Mayo Clinic proceedings.

[150]  A. Camm,et al.  Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: an insight from survival trials , 2007, Journal of hypertension.

[151]  R. Devereux,et al.  Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial , 2007, Hypertension.

[152]  A. Hoes,et al.  Awareness, treatment and control of hypertension: the ‘rule of halves’ in an era of risk-based treatment of hypertension , 2007, Journal of Human Hypertension.

[153]  L. de Jong-van den Berg,et al.  The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate. , 2007, British journal of clinical pharmacology.

[154]  A. Stanton,et al.  Aliskiren Reduces Blood Pressure and Suppresses Plasma Renin Activity in Combination With a Thiazide Diuretic, an Angiotensin-Converting Enzyme Inhibitor, or an Angiotensin Receptor Blocker , 2007, Hypertension.

[155]  W. Elliott,et al.  Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis , 2007, The Lancet.

[156]  P. Poole‐Wilson,et al.  Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET) , 2007, Heart.

[157]  G. Mancia,et al.  Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis , 2007, Hypertension.

[158]  A. de la Sierra,et al.  Undiagnosed obesity in hypertension: Clinical and therapeutic implications , 2007, Blood pressure.

[159]  H. Krum,et al.  Novel therapies blocking the renin–angiotensin–aldosterone system in the management of hypertension and related disorders , 2007, Journal of hypertension.

[160]  S. Kjeldsen,et al.  Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure , 2007, Journal of hypertension.

[161]  V. Feigin,et al.  Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region , 2007, Journal of hypertension.

[162]  D. Calhoun,et al.  Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide , 2007, Journal of hypertension.

[163]  D. Calhoun.  Low‐Dose Aldosterone Blockade as a New Treatment Paradigm for Controlling Resistant Hypertension , 2007, Journal of clinical hypertension.

[164]  P. Kokkinos,et al.  Exercise Capacity and Blood Pressure Associations With Left Ventricular Mass in Prehypertensive Individuals , 2007, HYPERTENSION.

[165]  M. Woodward,et al.  Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) , 2005, Heart.

[166]  G. Parati,et al.  Secondary Hypertension: Sleep Apnea , 2007 .

[167]  W. Elliott.  Chapter 8 – Secondary Hypertension: Renovascular Hypertension , 2007 .

[168]  E. Bravo.  Chapter 9 – Secondary Hypertension: Mineralocorticoid Excess States , 2007 .

[169]  T. Einarson,et al.  Hypertenion: Sensitivity of Patient Outcomes to Pharmacist Interventions. Part II: Systematic Review and Meta-Analysis in Hypertension Management , 2007, The Annals of pharmacotherapy.

[170]  J. Fleetham,et al.  Impact of Continuous Positive Airway Pressure Therapy on Blood Pressure in Patients with Obstructive Sleep Apnea Hypopnea: A Meta-analysis of Randomized Controlled Trials , 2007, Lung.

[171]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[172]  J. Manson,et al.  The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). , 2006, Circulation.

[173]  Jeannie K. Lee,et al.  Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. , 2006, JAMA.

[174]  E. Porteri,et al.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. , 2006, Journal of the American College of Cardiology.

[175]  Z. Tran,et al.  Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. , 2006, American journal of hypertension.

[176]  D. Calhoun,et al.  Primary Aldosteronism: Diagnosis and Treatment , 2006, Journal of clinical hypertension.

[177]  H. Neumann,et al.  Pheochromocytoma: presentation, diagnosis and treatment. , 2006, Journal of hypertension.

[178]  M Alan Brookhart,et al.  Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.

[179]  Serguei V. S. Pakhomov,et al.  Systolic and diastolic heart failure in the community. , 2006, JAMA.

[180]  T. Craven,et al.  Progression of atherosclerotic renovascular disease: A prospective population-based study. , 2006, Journal of vascular surgery.

[181]  Keith C. Norris,et al.  Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[182]  K. Ogunyankin,et al.  Validity of Revised Doppler Echocardiographic Algorithms and Composite Clinical and Angiographic Data in Diagnosis of Diastolic Dysfunction , 2006, Echocardiography.

[183]  C. Wiysonge,et al.  How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis , 2006, Journal of hypertension.

[184]  C. Agyemang,et al.  Prevalence and management of hypertension among Turkish, Moroccan and native Dutch ethnic groups in Amsterdam, the Netherlands: the Amsterdam Health Monitor Survey , 2006, Journal of hypertension.

[185]  H. Struijker‐Boudier,et al.  Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.

[186]  J. Laragh,et al.  Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial , 2006, Journal of hypertension.

[187]  P. Lucassen,et al.  Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose. , 2006, The Cochrane database of systematic reviews.

[188]  C. Del Mar,et al.  Exercise for overweight or obesity. , 2006, The Cochrane database of systematic reviews.

[189]  S. Yusuf,et al.  Effect of ramipril on the incidence of diabetes. , 2006, The New England journal of medicine.

[190]  K. Cummings,et al.  Lifetime cumulative exposure to secondhand smoke and risk of myocardial infarction in never smokers: results from the Western New York health study, 1995-2001. , 2006, Archives of internal medicine.

[191]  L. Kalra,et al.  The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials , 2006, Journal of hypertension.

[192]  H. Raff,et al.  Cushing's Syndrome: important issues in diagnosis and management. , 2006, The Journal of clinical endocrinology and metabolism.

[193]  M. Laakso,et al.  Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial , 2006, The Lancet.

[194]  Sverker Jern,et al.  Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. , 2006, JAMA.

[195]  S. Grundy,et al.  Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study , 2006, The Lancet.

[196]  B. Kestenbaum,et al.  Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease , 2006, Annals of Internal Medicine.

[197]  R. Anziano,et al.  Long-term fatty fish consumption and renal cell carcinoma incidence in women. , 2006, JAMA.

[198]  M. Hennerici,et al.  High-dose atorvastatin after stroke or transient ischemic attack. , 2006, The New England journal of medicine.

[199]  A. Mainous,et al.  Long-term prognostic value of resting heart rate in subjects with prehypertension. , 2006, American journal of hypertension.

[200]  R. Sarzani,et al.  Angiotensin receptor blockers and myocardial infarction: the importance of dosage. , 2006, Journal of hypertension.

[201]  F Boomsma,et al.  Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy. , 2006, Kidney international.

[202]  G. Bakris,et al.  Thiazide Diuretics, Potassium, and the Development of Diabetes: A Quantitative Review , 2006, Hypertension.

[203]  H. Clark,et al.  Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[204]  T. Heise,et al.  Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients , 2006, Journal of hypertension.

[205]  Vandana Sundaram,et al.  Quality Improvement Strategies for Hypertension Management: A Systematic Review , 2006, Medical care.

[206]  M. Pfeffer,et al.  Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. , 2006, American heart journal.

[207]  J. Staessen,et al.  Carotid Intima-Media Thickness and Antihypertensive Treatment: A Meta-Analysis of Randomized Controlled Trials , 2006, Stroke.

[208]  G. Mancia,et al.  Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial , 2006, Journal of hypertension.

[209]  James B Seward,et al.  Left atrial size: physiologic determinants and clinical applications. , 2006, Journal of the American College of Cardiology.

[210]  G. Mancia,et al.  Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? , 2006, Annals of Internal Medicine.

[211]  Tom Greene,et al.  Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.

[212]  N. Poulter,et al.  Improvement in hypertension management in England: results from the Health Survey for England 2003 , 2006, Journal of hypertension.

[213]  M. Woodward,et al.  Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial , 2006, Journal of hypertension.

[214]  G. Eknoyan,et al.  Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2006, Kidney international.

[215]  Ira Tabas,et al.  Letter by Williams and Tabas regarding article "atherosclerosis 2005: recent discoveries and novel hypotheses". , 2006, Circulation.

[216]  Roberto Sega,et al.  Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure , 2006, Hypertension.

[217]  G. Parati,et al.  Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study , 2006, Journal of hypertension.

[218]  Neil Chapman,et al.  Quantification of topological changes in retinal vascular architecture in essential and malignant hypertension , 2006, Journal of hypertension.

[219]  G. Nguyen.  Renin/prorenin receptors. , 2006, Kidney international.

[220]  E. Mannarino,et al.  Different Impact of the Metabolic Syndrome on Left Ventricular Structure and Function in Hypertensive Men and Women , 2006, Hypertension.

[221]  S. Oparil,et al.  Feasibility of treating prehypertension with an angiotensin-receptor blocker. , 2006, The New England journal of medicine.

[222]  Michael Proschan,et al.  Effects of Comprehensive Lifestyle Modification on Diet, Weight, Physical Fitness, and Blood Pressure Control: 18-Month Results of a Randomized Trial , 2006, Annals of Internal Medicine.

[223]  P. Okin,et al.  Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE Study , 2006, Journal of hypertension.

[224]  R. Schmieder.  Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum? , 2006, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[225]  Giuseppe Mancia,et al.  Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. , 2006, Journal of hypertension.

[226]  G. Viberti,et al.  Evidence for renoprotection by blockade of the renin–angiotensin–aldosterone system in hypertension and diabetes , 2006, Journal of Human Hypertension.

[227]  Silvia G Priori,et al.  Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. , 2006, European heart journal.

[228]  A. Adler,et al.  Renoprotective effects of renin-angiotensin-system inhibitors , 2006, The Lancet.

[229]  R. Kunz,et al.  Renoprotective effects of renin-angiotensin-system inhibitors , 2006, The Lancet.

[230]  Jeroen J. Bax,et al.  The long-term prognostic value of the resting and postexercise ankle-brachial index. , 2006, Archives of internal medicine.

[231]  Alice Stanton,et al.  Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study , 2006, Circulation.

[232]  William Stewart,et al.  Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[233]  M. Nijland,et al.  Nutrient-restricted fetus and the cardio–renal connection in hypertensive offspring , 2006, Expert review of cardiovascular therapy.

[234]  M. Yılmaz,et al.  Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients , 2006, Journal of hypertension.

[235]  Tine Willum Hansen,et al.  Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. , 2006, American journal of hypertension.

[236]  P. Elliott,et al.  Blood pressure and the global burden of disease 2000. Part 1: Estimates of blood pressure levels , 2006, Journal of hypertension.

[237]  K. Borch-Johnsen,et al.  Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study. , 2006, Diabetes care.

[238]  Yan Li,et al.  Ambulatory Arterial Stiffness Index Derived From 24-Hour Ambulatory Blood Pressure Monitoring , 2006, Hypertension.

[239]  F Xavier Pi-Sunyer,et al.  Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. , 2006, JAMA.

[240]  P. Kowey,et al.  Predictors of adverse outcome among patients with hypertension and coronary artery disease. , 2006, Journal of the American College of Cardiology.

[241]  B. Davis,et al.  Cardiovascular Outcomes in High-Risk Hypertensive Patients Stratified by Baseline Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[242]  Tine Willum Hansen,et al.  Prognostic Value of Aortic Pulse Wave Velocity as Index of Arterial Stiffness in the General Population , 2006, Circulation.

[243]  Bryan Williams,et al.  Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials , 2006, Journal of hypertension.

[244]  J. Lüdemann,et al.  Regional disparities of hypertension prevalence and management within Germany , 2006, Journal of hypertension.

[245]  R. Devereux,et al.  Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). , 2006, American heart journal.

[246]  K. Curtis,et al.  Combined oral contraceptive use among women with hypertension: a systematic review. , 2006, Contraception.

[247]  Yasmin,et al.  Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. , 2006, American journal of hypertension.

[248]  M. Morabito,et al.  Weather-Related Changes in 24-Hour Blood Pressure Profile: Effects of Age and Implications for Hypertension Management , 2006, Hypertension.

[249]  Yutaka Imai,et al.  Prognostic Significance for Stroke of a Morning Pressor Surge and a Nocturnal Blood Pressure Decline: The Ohasama Study , 2006, Hypertension.

[250]  Frank M. Sacks,et al.  Dietary Approaches to Prevent and Treat Hypertension: A Scientific Statement From the American Heart Association , 2006, Hypertension.

[251]  A. Caruso,et al.  Cardiovascular risk factors in healthy women with previous gestational hypertension. , 2006, The Journal of clinical endocrinology and metabolism.

[252]  M. al’Absi,et al.  Blood pressure stress reactivity and left ventricular mass in a random community sample of African-American and caucasian men and women. , 2006, The American journal of cardiology.

[253]  Deepak L. Bhatt,et al.  International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. , 2006, JAMA.

[254]  T. Chikritzhs,et al.  Moderate alcohol use and reduced mortality risk: Systematic error in prospective studies , 2006 .

[255]  K. Narkiewicz,et al.  Update on Hypertension Management: Obstructive sleep apnea and hypertension , 2006, Journal of hypertension.

[256]  A. Maggioni,et al.  Rationale and design of the GISSI-Atrial Fibrillation trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence , 2006, Journal of cardiovascular medicine.

[257]  R. Fogari,et al.  Losartan and Prevention of Atrial Fibrillation Recurrence in Hypertensive Patients , 2006, Journal of cardiovascular pharmacology.

[258]  R. Devereux,et al.  Does long‐term losartan‐ vs atenolol‐based antihypertensive treatment influence collagen markers differently in hypertensive patients? A LIFE substudy , 2006, Blood pressure.

[259]  P. Nilsson,et al.  The effects of thiazolidinediones on blood pressure levels – A systematic review , 2006, Blood pressure.

[260]  L. Nieman,et al.  Cushing's syndrome , 2005 .

[261]  T. Ohkubo,et al.  [The Ohasama study]. , 2004, Nihon rinsho. Japanese journal of clinical medicine.

[262]  Jennifer J. Otten,et al.  DRI, Dietary reference intakes : the essential guide to nutrient requirements , 2006 .

[263]  W. Elliott.  Prevention of Cardiovascular Events With an Antihypertensive Regimen of Amlodipine Adding Perindopril as Required Versus Atenolol Adding Bendroflumethiazide as Required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A Multicentre Randomised Controlled Tri , 2006 .

[264]  K. Fotiadis,et al.  Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study. , 2006, American journal of hypertension.

[265]  A. Zanchetti,et al.  Hypertensive myocardial fibrosis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[266]  G. Mancia,et al.  New-onset diabetes and antihypertensive drugs. , 2006, Journal of hypertension.

[267]  G. Mancia.  Role of outcome trials in providing information on antihypertensive treatment: importance and limitations. , 2006, American journal of hypertension.

[268]  B. Zinman,et al.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.

[269]  L. Smeeth,et al.  Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis , 2005, The Lancet.

[270]  R. Facchetti,et al.  Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study , 2005, Journal of hypertension.

[271]  Yuichiro Oka,et al.  Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis. , 2005, Internal medicine.

[272]  Li-sheng Liu,et al.  The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients , 2005, Journal of hypertension.

[273]  G. Paolisso,et al.  Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study. , 2005, American journal of hypertension.

[274]  M. Woodward,et al.  Joint Effects of Systolic Blood Pressure and Serum Cholesterol on Cardiovascular Disease in the Asia Pacific Region , 2005, Circulation.

[275]  J. Després,et al.  Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. , 2005, The New England journal of medicine.

[276]  K. Stronks,et al.  Prevalence, awareness, treatment, and control of hypertension among Black Surinamese, South Asian Surinamese and White Dutch in Amsterdam, The Netherlands: the SUNSET study , 2005, Journal of hypertension.

[277]  G. Navis,et al.  The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial , 2005, Journal of hypertension.

[278]  P. Gosse,et al.  Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study , 2005, Journal of hypertension.

[279]  Tom Fahey,et al.  Educational and organisational interventions used to improve the management of hypertension in primary care: a systematic review. , 2005, The British journal of general practice : the journal of the Royal College of General Practitioners.

[280]  G. Reboldi,et al.  Do angiotensin II receptor blockers increase the risk of myocardial infarction? , 2005, European heart journal.

[281]  Erland Erdmann,et al.  Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial , 2005, The Lancet.

[282]  E. Lewis,et al.  Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. , 2005, Journal of the American Society of Nephrology : JASN.

[283]  B. Gray.  Intervention for renal artery stenosis: endovascular and surgical roles , 2005, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[284]  R H Fagard,et al.  Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice , 2005, Journal of Human Hypertension.

[285]  R. Schmieder,et al.  Additional antiproteinuric effect of ultrahigh dose candesartan: a double-blind, randomized, prospective study. , 2005, Journal of the American Society of Nephrology : JASN.

[286]  M. Gus.  Superiority of ambulatory over clinic blood pressure measurement. , 2005, Hypertension.

[287]  Véronique A. Cornelissen,et al.  Effects of Endurance Training on Blood Pressure, Blood Pressure–Regulating Mechanisms, and Cardiovascular Risk Factors , 2005, Hypertension.

[288]  Sally Morton,et al.  Meta-Analysis: Chronic Disease Self-Management Programs for Older Adults , 2005, Annals of Internal Medicine.

[289]  M. Woodward,et al.  Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy , 2005, Circulation.

[290]  G. Nickenig,et al.  Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005, The New England journal of medicine.

[291]  J. O’Keefe,et al.  Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. , 2005, Journal of the American College of Cardiology.

[292]  A. Gotto.  Review of primary and secondary prevention trials with lovastatin, pravastatin, and simvastatin. , 2005, The American journal of cardiology.

[293]  N. Poulter,et al.  Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA). , 2005, The American journal of cardiology.

[294]  H. Parving,et al.  Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. , 2005, Kidney international.

[295]  P. Alcântara,et al.  Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study , 2005, Journal of hypertension.

[296]  M. Wellner,et al.  Aliskiren, a Human Renin Inhibitor, Ameliorates Cardiac and Renal Damage in Double-Transgenic Rats , 2005, Hypertension.

[297]  W. Ambrosius,et al.  Improvement in Blood Pressure With Inhibition of the Epithelial Sodium Channel in Blacks With Hypertension , 2005, Hypertension.

[298]  D. Levy,et al.  Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals: The Framingham Heart Study , 2005, Circulation.

[299]  J. Salonen,et al.  Left atrium size and the risk of cardiovascular death in middle-aged men. , 2005, Archives of internal medicine.

[300]  Yutaka Imai,et al.  Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. , 2005, Journal of the American College of Cardiology.

[301]  L. Bouter,et al.  Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study , 2005, Circulation.

[302]  G. Hankey,et al.  Preventable stroke and stroke prevention , 2005, Journal of thrombosis and haemostasis : JTH.

[303]  G. Mancia,et al.  Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study , 2005, Journal of hypertension.

[304]  A. Zanchetti,et al.  Ambulatory blood pressure, target organ damage and left atrial size in never-treated essential hypertensive individuals , 2005, Journal of hypertension.

[305]  B. Winblad,et al.  The age-dependent relation of blood pressure to cognitive function and dementia , 2005, The Lancet Neurology.

[306]  R. Fagard,et al.  ESC Study Group of Sports Cardiology Recommendations for participation in leisure-time physical activities and competitive sports for patients with hypertension , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[307]  Heejung Bang,et al.  Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. , 2005, Diabetes care.

[308]  J. Staessen,et al.  Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention , 2005, Hypertension.

[309]  G. V. van Montfrans,et al.  Value of routine funduscopy in patients with hypertension: systematic review , 2005, BMJ : British Medical Journal.

[310]  D. McClish,et al.  Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. , 2005, The Journal of clinical endocrinology and metabolism.

[311]  A. Hofman,et al.  Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE) , 2005, Alzheimer's & Dementia.

[312]  Margus Viigimaa,et al.  Daily usage and efficiency of remote home monitoring in hypertensive patients over a one-year period , 2005, Journal of telemedicine and telecare.

[313]  J. Rouleau,et al.  Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. , 2005, Journal of the American Society of Nephrology : JASN.

[314]  Alice Stanton,et al.  Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality: The Dublin Outcome Study , 2005, Hypertension.

[315]  Karl Swedberg,et al.  Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. , 2005, European heart journal.

[316]  R. Wing,et al.  Long-term weight loss maintenance. , 2005, The American journal of clinical nutrition.

[317]  Neil Chapman,et al.  Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. , 2005, Archives of internal medicine.

[318]  S. Yusuf,et al.  Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .

[319]  G. Eknoyan,et al.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.

[320]  A. Zanchetti.  Evidence-based medicine in hypertension: what type of evidence? , 2005, Journal of hypertension.

[321]  M. Moser.  Are Lifestyle Interventions in the Management of Hypertension Effective? How Long Should You Wait Before Starting Specific Medical Therapy? An Ongoing Debate , 2005, Journal of clinical hypertension.

[322]  G. Cerasola,et al.  Influence of metabolic syndrome on hypertension‐related target organ damage , 2005, Journal of internal medicine.

[323]  J. Mackenbach,et al.  Inequalities in the prevalence of smoking in the European Union: comparing education and income. , 2005, Preventive medicine.

[324]  G. Mancia,et al.  Carotid wall composition in hypertensive patients after 4-year treatment with lacidipine or atenolol: an echoreflectivity study , 2005, Journal of Hypertension.

[325]  F. Fuchs,et al.  Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension , 2005, Journal of Human Hypertension.

[326]  G. Mancia,et al.  Relationship of Office, Home, and Ambulatory Blood Pressure to Blood Glucose and Lipid Variables in the PAMELA Population , 2005, Hypertension.

[327]  E. Mannarino,et al.  Metabolic Syndrome Is Associated With Aortic Stiffness in Untreated Essential Hypertension , 2005, Hypertension.

[328]  H. Diener,et al.  Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention: Principal Results of a Prospective Randomized Controlled Study (MOSES) , 2005, Stroke.

[329]  G. Parati,et al.  Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA) , 2005, Journal of hypertension.

[330]  G. Leoncini,et al.  Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients , 2005, Journal of internal medicine.

[331]  G. Bakris,et al.  The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. , 2005, Archives of internal medicine.

[332]  B. Davis,et al.  Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2005, Archives of internal medicine.

[333]  S. Fowler,et al.  The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial , 2005, Annals of Internal Medicine.

[334]  A. Rissanen,et al.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study , 2005, The Lancet.

[335]  Roberto Sega,et al.  Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population: Follow-Up Results From the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study , 2005, Circulation.

[336]  Barry R. Davis,et al.  Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril , 2005 .

[337]  F. Magrini,et al.  Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: The Evaluation of Target Organ Damage in Hypertension study , 2005, Journal of hypertension.

[338]  G. Mancia,et al.  The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction , 2005, Acta Diabetologica.

[339]  A. Barnett.  Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study* , 2005, Acta Diabetologica.

[340]  Empar Lurbe,et al.  Prevalence, Persistence, and Clinical Significance of Masked Hypertension in Youth , 2005, Hypertension.

[341]  Yutaka Imai,et al.  Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. , 2005, Journal of hypertension.

[342]  Tine Willum Hansen,et al.  Ambulatory Blood Pressure and Mortality: A Population-Based Study , 2005, Hypertension.

[343]  J. Manson,et al.  A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women , 2005, The New England journal of medicine.

[344]  K. Wasserman,et al.  Statement on exercise: American College of Chest Physicians/American Thoracic Society--exercise for fun or profit? , 2005, Chest.

[345]  G. Beck,et al.  The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study , 2005, Annals of Internal Medicine.

[346]  A. Hofman,et al.  The Study on COgnition and Prognosis in the Elderly (SCOPE) – Major CV events and stroke in subgroups of patients , 2005, Blood pressure.

[347]  T. Kahan,et al.  Irbesartan and atenolol improve diastolic function in patients with hypertensive left ventricular hypertrophy , 2005, Journal of hypertension.

[348]  Gianni Tognoni,et al.  Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). , 2005, American heart journal.

[349]  P. Poole‐Wilson,et al.  Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial , 2005, Journal of hypertension.

[350]  C. Bulpitt,et al.  CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) Pilot Trial: rationale and design. , 2005, Journal of hypertension.

[351]  G. Remuzzi,et al.  Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial , 2005, The Lancet.

[352]  A. Smit,et al.  Effects of Fosinopril and Pravastatin on Carotid Intima-Media Thickness in Subjects With Increased Albuminuria , 2005, Stroke.

[353]  M. Nieminen,et al.  Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. , 2005, Journal of the American College of Cardiology.

[354]  R. Schmieder,et al.  Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients , 2005, Circulation.

[355]  B. Sibai,et al.  Treatment of hypertensive complications in pregnancy. , 2005, Current pharmaceutical design.

[356]  E. Lewis,et al.  Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[357]  A. Bikhazi,et al.  Effect of insulin and angiotensin II receptor subtype-1 antagonist on myocardial remodelling in rats with insulin-dependent diabetes mellitus , 2005, Journal of hypertension.

[358]  Yutaka Imai,et al.  Ambulatory Blood Pressure and 10-Year Risk of Cardiovascular and Noncardiovascular Mortality: The Ohasama Study , 2005, Hypertension.

[359]  S. Paul,et al.  COSSACS (Continue or Stop post-Stroke Antihypertensives Collaborative Study): rationale and design , 2005, Journal of hypertension.

[360]  J. Schwartz,et al.  Short- and Long-Term Incidence of Stroke in White-Coat Hypertension , 2005, Hypertension.

[361]  R. Fagard,et al.  Effect of resistance training on resting blood pressure: a meta-analysis of randomized controlled trials , 2005, Journal of hypertension.

[362]  M. Nieminen,et al.  Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study , 2005, Hypertension.

[363]  P. Poulsen,et al.  Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study. , 2005, Diabetes care.

[364]  J. Martin,et al.  Stroke and Severe Preeclampsia and Eclampsia: A Paradigm Shift Focusing on Systolic Blood Pressure , 2005, Obstetrics and gynecology.

[365]  A. Zeiher,et al.  Endothelial Function: Cardiac Events , 2005, Circulation.

[366]  K. Reynolds,et al.  Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.

[367]  W. Oelkers.  Drospirenone in combination with estrogens: for contraception and hormone replacement therapy , 2005, Climacteric : the journal of the International Menopause Society.

[368]  G. Mancia,et al.  Angiotensin receptor blockers: Therapeutic targets and cardiovascular protection , 2005, Blood pressure.

[369]  J. Paolini,et al.  Ezetimibe , 2005, Clinical pharmacokinetics.

[370]  B. Casadei,et al.  Is there a strong rationale for deferring elective surgery in patients with poorly controlled hypertension? , 2005, Journal of hypertension.

[371]  Alan C. Wilson,et al.  Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. , 2005, The American journal of cardiology.

[372]  S. Haffner,et al.  Effects of Cigarette Smoking , Diabetes , High Cholesterol , and Hypertension on All-Cause Mortality and Cardiovascular Disease Mortality in Mexican Americans , 2005 .

[373]  C. Palmer,et al.  Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial. , 2004, Archives of internal medicine.

[374]  G. Mancia,et al.  Different Effects of Antihypertensive Regimens Based on Fosinopril or Hydrochlorothiazide With or Without Lipid Lowering by Pravastatin on Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of PHYLLIS—A Randomized Double-Blind Trial , 2004, Stroke.

[375]  G. Mancia,et al.  Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial. , 2004, American journal of hypertension.

[376]  A. Naska,et al.  Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. , 2004, International journal of epidemiology.

[377]  T. Kurtz,et al.  Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin–angiotensin system , 2004, Journal of hypertension.

[378]  A. Stanton,et al.  Determinants of white-coat hypertension , 2004, Blood pressure monitoring.

[379]  S. Verma,et al.  Angiotensin receptor blockers and myocardial infarction , 2004, BMJ : British Medical Journal.

[380]  Mark A Pereira,et al.  Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. , 2004, JAMA.

[381]  M. Nieminen,et al.  Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. , 2004, JAMA.

[382]  M. Nieminen,et al.  Prognostic significance of left ventricular mass change during treatment of hypertension. , 2004, JAMA.

[383]  A. Mueck,et al.  Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women. , 2004, Maturitas.

[384]  M. Pfeffer,et al.  Angiotensin-converting-enzyme inhibition in stable coronary artery disease. , 2004, The New England journal of medicine.

[385]  P. Libby,et al.  Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure The CAMELOT Study: A Randomized Controlled Trial , 2004 .

[386]  P. Raskin,et al.  Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. , 2004, JAMA.

[387]  G. Remuzzi,et al.  Preventing microalbuminuria in type 2 diabetes. , 2004, The New England journal of medicine.

[388]  G. Braunstein,et al.  Meta-Analysis: Angiotensin-Receptor Blockers in Chronic Heart Failure and High-Risk Acute Myocardial Infarction , 2004, Annals of Internal Medicine.

[389]  K. Yoshinaga,et al.  Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients. , 2004, American journal of hypertension.

[390]  F. Magrini,et al.  Retinal microvascular changes and target organ damage in untreated essential hypertensives , 2004, Journal of hypertension.

[391]  P. Torjesen,et al.  Low-renin status in therapy-resistant hypertension: a clue to efficient treatment , 2004, Journal of hypertension.

[392]  Carole Dufouil,et al.  The Association Between Blood Pressure, Hypertension, and Cerebral White Matter Lesions: Cardiovascular Determinants of Dementia Study , 2004, Hypertension.

[393]  J. Kleijnen,et al.  Systematic Review: Antihypertensive Drug Therapy in Black Patients , 2004, Annals of Internal Medicine.

[394]  S. Deitcher,et al.  Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. , 2004, Archives of internal medicine.

[395]  T. MacDonald,et al.  The current epidemic of primary aldosteronism: causes and consequences. , 2004, Journal of hypertension.

[396]  A. Hofman,et al.  Cerebral white matter lesions and the risk of dementia. , 2004, Archives of neurology.

[397]  G. Pozza,et al.  Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina). , 2004, Diabetes, nutrition & metabolism.

[398]  F. Magrini,et al.  Metabolic syndrome and target organ damage in untreated essential hypertensives , 2004, Journal of hypertension.

[399]  C. Bulpitt,et al.  Prognostic Significance of Electrocardiographic Voltages and Their Serial Changes in Elderly With Systolic Hypertension , 2004, Hypertension.

[400]  A. Hofman,et al.  Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE). , 2004, Journal of the American College of Cardiology.

[401]  M. Nieminen,et al.  Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial , 2004, Circulation.

[402]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[403]  P. Poole‐Wilson,et al.  Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial , 2004, The Lancet.

[404]  A. Zanchetti,et al.  On the importance of estimating renal function for cardiovascular risk assessment. , 2004, Journal of hypertension.

[405]  G. Bakris,et al.  Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension. , 2004, American journal of hypertension.

[406]  R. Fagard,et al.  Prognostic significance of various characteristics of out-of-the-office blood pressure , 2004, Journal of hypertension.

[407]  B. Brenner,et al.  Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy , 2004, Circulation.

[408]  John H Fuller,et al.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.

[409]  F. Magrini,et al.  Different Effects of Antihypertensive Therapies Based on Losartan or Atenolol on Ultrasound and Biochemical Markers of Myocardial Fibrosis: Results of a Randomized Trial , 2004, Circulation.

[410]  R. Nesto.  C‐reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin‐sensitizing treatment with thiazolidinediones , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[411]  R. Schall,et al.  Old antihypertensives and new diabetes , 2004, Journal of hypertension.

[412]  M. Safar,et al.  Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects , 2004, Journal of hypertension.

[413]  E. O’Brien,et al.  Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study. , 2004, American journal of hypertension.

[414]  J. Tuomilehto,et al.  Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: The NESTOR* study , 2004, Journal of hypertension.

[415]  M. Horowitz,et al.  Blood pressure responses in healthy older people to 50 g carbohydrate drinks with differing glycaemic effects , 2004, British Journal of Nutrition.

[416]  H. Diener,et al.  Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial , 2004, The Lancet.

[417]  曲东锋.  Stroke Prevention by Aggressive Reduction in Cholesterol Levels , 2004 .

[418]  S. Hallan,et al.  Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[419]  S. Yusuf,et al.  Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Int , 2004, American heart journal.

[420]  A. Smit,et al.  Effects of amlodipine and lisinopril on intima–media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial) , 2004, Journal of hypertension.

[421]  R. Schmieder,et al.  Effect of Irbesartan Versus Atenolol on Left Ventricular Mass and Voltage: Results of the CardioVascular Irbesartan Project , 2004, Hypertension.

[422]  A. Hofman,et al.  Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. , 2004, Investigative ophthalmology & visual science.

[423]  J. Laragh,et al.  Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial , 2004, The Lancet.

[424]  J. Laragh,et al.  Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial , 2004, The Lancet.

[425]  G. Mancia,et al.  Absolute and relative changes in carotid intima–media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA) , 2004, Journal of hypertension.

[426]  M. Nieminen,et al.  Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy , 2004, Journal of Human Hypertension.

[427]  F. Rodríguez‐Artalejo,et al.  Blood Pressure Control and Physician Management of Hypertension in Hospital Hypertension Units in Spain , 2004, Hypertension.

[428]  V. Somers,et al.  Early Morning Attenuation of Endothelial Function in Healthy Humans , 2004, Circulation.

[429]  P. Bandosz,et al.  Arterial hypertension in Poland in 2002 , 2004, Journal of Human Hypertension.

[430]  U. Kintscher,et al.  Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity , 2004, Circulation.

[431]  D. Goldstein,et al.  Diagnosis and localization of pheochromocytoma. , 2004, Hypertension.

[432]  G. Reboldi,et al.  Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects , 2004, Hypertension.

[433]  P. Corey,et al.  Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence. , 2004, Archives of internal medicine.

[434]  N. Hollenberg.  Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. , 2004, Current hypertension reports.

[435]  D. Rizzoni,et al.  Left Ventricular Concentric Geometry During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients , 2004, Hypertension.

[436]  C. Bulpitt,et al.  Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial , 2004, Journal of hypertension.

[437]  Gilles Chatellier,et al.  Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. , 2004, JAMA.

[438]  G. Parati,et al.  Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis , 2004, Journal of hypertension.

[439]  S. Takishita,et al.  [Centrally-acting antihypertensive drugs]. , 2004, Nihon rinsho. Japanese journal of clinical medicine.

[440]  R. Devereux,et al.  N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study. , 2004, Journal of hypertension.

[441]  B. Franklin,et al.  Exercise and Hypertension , 2004 .

[442]  S. Hosoda,et al.  Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

[443]  Jan A Staessen,et al.  Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial. , 2004, JAMA.

[444]  K. Swedberg,et al.  Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. , 2004, Journal of the American College of Cardiology.

[445]  S. Hussain.  Progestogen-only pills and high blood pressure: is there an association? A literature review. , 2004, Contraception.

[446]  P. Sarafidis,et al.  Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study , 2004, Journal of Human Hypertension.

[447]  I. Ilias,et al.  Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. , 2004, The Journal of clinical endocrinology and metabolism.

[448]  Trefor Owen Morgan,et al.  Effect of different antihypertensive drug classes on central aortic pressure. , 2004, American journal of hypertension.

[449]  A. Gotto,et al.  The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). , 2004, The American journal of cardiology.

[450]  M. Godwin,et al.  Randomised equivalence trial comparing three month and six month follow up of patients with hypertension by family practitioners , 2004, BMJ : British Medical Journal.

[451]  P. Whelton,et al.  Effect of dietary fiber intake on blood pressure: a randomized, double-blind, placebo-controlled trial , 2004, Journal of hypertension.

[452]  A. Stenehjem,et al.  Reproducibility of blood pressure variability, white‐coat effect and dipping pattern in untreated, uncomplicated and newly diagnosed essential hypertension , 2004, Blood pressure.

[453]  S. Kjeldsen,et al.  Never mind the quality, feel the width – ALLHAT revisited , 2004, Blood pressure.

[454]  K. Reynolds,et al.  Worldwide prevalence of hypertension: a systematic review , 2004, Journal of hypertension.

[455]  L. Stead,et al.  Physician advice for smoking cessation. , 2004, The Cochrane database of systematic reviews.

[456]  H. Neumann,et al.  The genetic basis of pheochromocytoma. , 2004, Frontiers of hormone research.

[457]  James B Seward,et al.  Risks for atrial fibrillation and congestive heart failure in patients >/=65 years of age with abnormal left ventricular diastolic relaxation. , 2004, The American journal of cardiology.

[458]  R. Fogari,et al.  Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension , 2004, European Journal of Clinical Pharmacology.

[459]  Carl J Pepine,et al.  A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. , 2003, JAMA.

[460]  M. Nieminen,et al.  Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study , 2003, Annals of Internal Medicine.

[461]  A. Zanchetti.  Costs of implementing recommendations on hypertension management given in recent guidelines. , 2003, Journal of hypertension.

[462]  G. MacGregor,et al.  How Far Should Salt Intake Be Reduced? , 2003, Hypertension.

[463]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[464]  C. Bulpitt,et al.  Results of the pilot study for the Hypertension in the Very Elderly Trial , 2003, Journal of hypertension.

[465]  Karl Swedberg,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[466]  F. Turnbull.  Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials , 2003, The Lancet.

[467]  C. de Ciuceis,et al.  Prognostic Significance of Small-Artery Structure in Hypertension , 2003, Circulation.

[468]  G. Rosano,et al.  Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. , 2003, European heart journal.

[469]  M. Stowasser,et al.  High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective’ screening of hypertensive patients , 2003, Journal of hypertension.

[470]  R. Devereux,et al.  Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. , 2003, American journal of hypertension.

[471]  S. Yusuf,et al.  Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[472]  Shah Ebrahim,et al.  JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .

[473]  T. Saruta,et al.  Long-term effects of intensive blood-pressure lowering on arterial wall stiffness in hypertensive patients. , 2003, American journal of hypertension.

[474]  Diederick E. Grobbee,et al.  Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2003, Hypertension.

[475]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Circulation.

[476]  J. Whitworth,et al.  2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension , 2003, Journal of hypertension.

[477]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[478]  N. Reichek,et al.  Hypertension and Left Ventricular Hypertrophy : The 4 E Effects of Eplerenone , Enalapril , and Eplerenone / Enalapril in Patients With Essential , 2003 .

[479]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.

[480]  K. Fox,et al.  Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) , 2003, The Lancet.

[481]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial , 2003, The Lancet.

[482]  M. Pfeffer,et al.  Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme , 2003, The Lancet.

[483]  L. Guize,et al.  Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population , 2003, Journal of hypertension.

[484]  M. Domanski,et al.  Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). , 2003, Journal of the American College of Cardiology.

[485]  Christopher H Schmid,et al.  Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis , 2003, Annals of Internal Medicine.

[486]  M. Nieminen,et al.  Regression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) Study , 2003, Circulation.

[487]  D. Panagiotakos,et al.  Status and management of hypertension in Greece: role of the adoption of a Mediterranean diet the Attica study , 2003, Journal of hypertension.

[488]  D. Sica,et al.  A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly. , 2003, Current hypertension reports.

[489]  L. Lindholm,et al.  Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study) , 2003, Journal of hypertension.

[490]  P. Greenland,et al.  Clinical practice. Selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing. , 2003, The New England journal of medicine.

[491]  P. Macfarlane,et al.  Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study , 2003, Circulation.

[492]  Markolf Hanefeld,et al.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. , 2003, JAMA.

[493]  P. Poole‐Wilson,et al.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.

[494]  R. Schmieder,et al.  A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. , 2003, The American journal of medicine.

[495]  I. Meredith,et al.  Use of arterial transfer functions for the derivation of aortic waveform characteristics , 2003, Journal of hypertension.

[496]  H. Diener,et al.  The ACCESS Study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors , 2003, Stroke.

[497]  N J Wald,et al.  Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials , 2003, BMJ : British Medical Journal.

[498]  N J Wald,et al.  A strategy to reduce cardiovascular disease by more than 80% , 2003, BMJ : British Medical Journal.

[499]  Fernando Costa,et al.  Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Ph , 2003, Circulation.

[500]  A. Ducharme,et al.  Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Trials , 2003, Circulation.

[501]  Mark B Pepys,et al.  C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.

[502]  Peter W de Leeuw,et al.  Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. , 2003, The New England journal of medicine.

[503]  H. Struijker‐Boudier,et al.  Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases , 2003, Circulation.

[504]  C. Cantet,et al.  Why is hypertension so frequently uncontrolled in secondary prevention? , 2003, Journal of hypertension.

[505]  P. Mehler,et al.  Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial. , 2003, American heart journal.

[506]  J. Staessen,et al.  Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003 , 2003, Journal of hypertension.

[507]  K. Kawecka-Jaszcz,et al.  Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypertension. , 2003, American journal of hypertension.

[508]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[509]  Thomas Lumley,et al.  Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. , 2003, JAMA.

[510]  H. Hense,et al.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. , 2003, JAMA.

[511]  A. Hofman,et al.  The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial , 2003, Journal of hypertension.

[512]  Paul G Shekelle,et al.  Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. , 2003, Journal of the American College of Cardiology.

[513]  H. Morita,et al.  Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. , 2003, Lancet.

[514]  L. Ruilope,et al.  Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes: Preterax in Albuminuria Regression: PREMIER , 2003, Hypertension.

[515]  S. Laurent,et al.  Aortic Stiffness Is an Independent Predictor of Fatal Stroke in Essential Hypertension , 2003, Stroke.

[516]  S. Tonstad,et al.  Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. , 2003, European heart journal.

[517]  W. White,et al.  Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension , 2003, Hypertension.

[518]  A. Hofman,et al.  Silent Brain Infarcts and White Matter Lesions Increase Stroke Risk in the General Population: The Rotterdam Scan Study , 2003, Stroke.

[519]  Yutaka Imai,et al.  European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement , 2003, Journal of hypertension.

[520]  Peter Sleight,et al.  Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. , 2003, JAMA.

[521]  G. Prescott,et al.  Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study , 2003, BMJ : British Medical Journal.

[522]  R. Collins,et al.  Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial , 2003, The Lancet.

[523]  G. Mancia,et al.  International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. , 2003, Journal of hypertension.

[524]  A. Zanchetti,et al.  Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers? , 2003, Journal of hypertension.

[525]  L. Lind,et al.  Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study , 2003, BMJ : British Medical Journal.

[526]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[527]  Kazuomi Kario,et al.  Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives: A Prospective Study , 2003, Circulation.

[528]  L. Lind,et al.  Isolated Ambulatory Hypertension Predicts Cardiovascular Morbidity in Elderly Men , 2003, Circulation.

[529]  L. Eberly,et al.  Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience. , 2003, Diabetes care.

[530]  C. Palmer,et al.  Outcomes With Nifedipine GITS or Co-Amilozide in Hypertensive Diabetics and Nondiabetics in Intervention as a Goal in Hypertension (INSIGHT) , 2003, Hypertension.

[531]  B. Howard,et al.  Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study. , 2003, Diabetes care.

[532]  C. Reid,et al.  A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. , 2003, The New England journal of medicine.

[533]  R. Maestri,et al.  Short-Term Heart Rate Variability Strongly Predicts Sudden Cardiac Death in Chronic Heart Failure Patients , 2003, Circulation.

[534]  J. Robertson,et al.  Dietary salt and hypertension: a scientific issue or a matter of faith? , 2003, Journal of evaluation in clinical practice.

[535]  W. Young,et al.  A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. , 2003, The Journal of clinical endocrinology and metabolism.

[536]  Maurizio Bentivoglio,et al.  Atrial Fibrillation in Hypertension: Predictors and Outcome , 2003, Hypertension.

[537]  Oluf Pedersen,et al.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.

[538]  Nancy R Cook,et al.  C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003, Circulation.

[539]  H. Morita,et al.  RETRACTED: Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial , 2003, The Lancet.

[540]  Douglas W Mahoney,et al.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.

[541]  D. O'Connor,et al.  Pharmacogenomics of hypertension , 2003, Current opinion in nephrology and hypertension.

[542]  G. Mancia,et al.  Treatment of Isolated Systolic Hypertension: The SHELL Study Results , 2003, Blood pressure.

[543]  C. Ballantyne.  Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA) , 2003 .

[544]  A. Logan,et al.  Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. , 2003, The American journal of medicine.

[545]  D. Blondheim,et al.  Expert consensus document on management of cardiovascular diseases during pregnancy. , 2003, European heart journal.

[546]  Barry R. Davis,et al.  Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). , 2002, JAMA.

[547]  B. Davis,et al.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.

[548]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[549]  R Brian Haynes,et al.  Helping patients follow prescribed treatment: clinical applications. , 2002, JAMA.

[550]  A. Heagerty,et al.  Vascular Structural and Functional Changes in Type 2 Diabetes Mellitus: Evidence for the Roles of Abnormal Myogenic Responsiveness and Dyslipidemia , 2002, Circulation.

[551]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[552]  N. Hollenberg,et al.  Literature alert , 2002 .

[553]  J. Laragh,et al.  Left ventricular mass change during treatment and outcome in patients with essential hypertension. , 2002, American journal of hypertension.

[554]  P. Macfarlane,et al.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.

[555]  Tom Greene,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.

[556]  C. Bulpitt,et al.  Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. , 2002, Archives of internal medicine.

[557]  G. Mancia,et al.  Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial , 2002, Circulation.

[558]  Majid Ezzati,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[559]  M. Kikuya,et al.  Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study , 2002, Journal of hypertension.

[560]  J. Bacharach,et al.  Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure , 2002, Vascular medicine.

[561]  A. Zanchetti,et al.  Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study , 2002, Journal of hypertension.

[562]  A. Zanchetti,et al.  Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials? , 2002, Journal of hypertension.

[563]  J. Ménard,et al.  Benefit and harm of low-dose aspirin in well-treated hypertensives at different baseline cardiovascular risk , 2002, Journal of hypertension.

[564]  Vic Hasselblad,et al.  Interventions used in disease management programmes for patients with chronic illnesswhich ones work? Meta-analysis of published reports , 2002, BMJ : British Medical Journal.

[565]  Jan A Staessen,et al.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. , 2002, Archives of internal medicine.

[566]  G. Mancia,et al.  Short- and Long-Term Neuroadrenergic Effects of Moderate Dietary Sodium Restriction in Essential Hypertension , 2002, Circulation.

[567]  Hans L Hillege,et al.  Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population , 2002, Circulation.

[568]  M. Nieminen,et al.  Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. , 2002, JAMA.

[569]  J. Redón,et al.  Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. , 2002, The New England journal of medicine.

[570]  K. Dickstein,et al.  Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial , 2002, The Lancet.

[571]  Necla Tugay Aytekin,et al.  Distribution of blood pressures in Gemlik District, north-west Turkey. , 2002, Health & social care in the community.

[572]  M. Nieminen,et al.  Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study , 2002, Journal of hypertension.

[573]  Jan A Staessen,et al.  Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial. , 2002, Journal of the American Society of Nephrology : JASN.

[574]  S. Taddei,et al.  Endothelial dysfunction in essential hypertension: clinical implications. , 2002, Journal of hypertension.

[575]  A. Zanchetti,et al.  Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy , 2002, Journal of hypertension.

[576]  Anil A. Bharath,et al.  Retinal vascular tree morphology: a semi-automatic quantification , 2002, IEEE Transactions on Biomedical Engineering.

[577]  G. Viberti,et al.  Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus: A Blood Pressure–Independent Effect , 2002, Circulation.

[578]  A. Quyyumi,et al.  Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.

[579]  M L Simoons,et al.  The Cardiology Information System: the need for data standards for integration of systems for patient care, registries and guidelines for clinical practice. , 2002, European heart journal.

[580]  D. Grobbee,et al.  Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials , 2002, Journal of hypertension.

[581]  F. Magrini,et al.  Assessment of carotid plaque composition in hypertensive patients by ultrasonic tissue characterization: a validation study , 2002, Journal of hypertension.

[582]  G. Mancia,et al.  Systolic and diastolic blood pressure control in antihypertensive drug trials. , 2002, Journal of hypertension.

[583]  Vikesh K. Singh,et al.  The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. , 2002, American journal of hypertension.

[584]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[585]  E. Bernal,et al.  Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study , 2002, Circulation.

[586]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[587]  R. Klein,et al.  Cerebral white matter lesions, retinopathy, and incident clinical stroke. , 2002, JAMA.

[588]  R. Fagard,et al.  Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium , 2002, Journal of hypertension.

[589]  R. Garay,et al.  Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. , 2002, The Journal of nutrition.

[590]  E. Ambrosioni,et al.  Use of Lipid‐Lowering Drugs and Blood Pressure Control in Patients With Arterial Hypertension , 2002, Journal of clinical hypertension.

[591]  G. Mancia,et al.  Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey , 2002, Journal of hypertension.

[592]  D. Altman,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[593]  L. Kuller,et al.  Prevention Conference VI: Diabetes and Cardiovascular disease: Writing Group I: epidemiology. , 2002, Circulation.

[594]  J. Rouleau,et al.  Angiotensin receptor blockers: powerful evidence with cardiovascular outcomes? , 2002, The Canadian journal of cardiology.

[595]  A. Zanchetti,et al.  Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy. , 2002, Journal of hypertension.

[596]  B. Howard,et al.  Mitral Ratio of Peak Early to Late Diastolic Filling Velocity as a Predictor of Mortality in Middle-Aged and Elderly Adults: The Strong Heart Study , 2002, Circulation.

[597]  G. Mancia,et al.  Radial, carotid and aortic distensibility in congestive heart failure: effects of high-dose angiotensin-converting enzyme inhibitor or low-dose association with angiotensin type 1 receptor blockade. , 2002, Journal of the American College of Cardiology.

[598]  S. Chow,et al.  Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight--the Chin-Shan Community Cardiovascular Cohort study. , 2002, Atherosclerosis.

[599]  C. Reid,et al.  `Reverse white-coat hypertension’ in older hypertensives , 2002, Journal of hypertension.

[600]  A Hofman,et al.  Hypertension and cerebral white matter lesions in a prospective cohort study. , 2002, Brain : a journal of neurology.

[601]  P. Kincaid‐smith,et al.  Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[602]  J. Bosch,et al.  Use of ramipril in preventing stroke: double blind randomised trial , 2002, BMJ : British Medical Journal.

[603]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[604]  François Gueyffier,et al.  J-Shaped Relationship between Blood Pressure and Mortality in Hypertensive Patients: New Insights from a Meta-Analysis of Individual-Patient Data , 2002, Annals of Internal Medicine.

[605]  R. Klein,et al.  Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. , 2002, JAMA.

[606]  A. de la Sierra,et al.  Silent cerebral white matter lesions in middle-aged essential hypertensive patients , 2002, Journal of hypertension.

[607]  P. Mehler,et al.  Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. , 2002, Kidney international.

[608]  M. al’Absi,et al.  Blood pressure responses to acute stress and left ventricular mass (The Hypertension Genetic Epidemiology Network Study). , 2002, The American journal of cardiology.

[609]  B. Williams,et al.  Microalbuminuria in essential hypertension: redefining the threshold. , 2002, Journal of hypertension.

[610]  J. Redón,et al.  Factors Related to the Occurrence of Microalbuminuria During Antihypertensive Treatment in Essential Hypertension , 2002, Hypertension.

[611]  J. Blacher,et al.  Central Pulse Pressure and Mortality in End-Stage Renal Disease , 2002, Hypertension.

[612]  Sudha Seshadri,et al.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.

[613]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[614]  Yuling Hong,et al.  Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study , 2002, Journal of hypertension.

[615]  M. Weber.  The 24-hour blood pressure pattern: does it have implications for morbidity and mortality? , 2002, The American journal of cardiology.

[616]  G. Assmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.

[617]  C. Mulrow,et al.  Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[618]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[619]  Jan A Staessen,et al.  Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups , 2002, Journal of hypertension.

[620]  F. Frey,et al.  Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade , 2002, Journal of hypertension.

[621]  S. Laurent,et al.  Aortic Stiffness Is an Independent Predictor of Primary Coronary Events in Hypertensive Patients: A Longitudinal Study , 2002, Hypertension.

[622]  A. Hofman,et al.  Prevalence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study , 2002, Stroke.

[623]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy , 2002 .

[624]  S. Li.  Oral contraceptives and the risk of myocardial infarction. , 2002, The New England journal of medicine.

[625]  J. V. van Engelshoven,et al.  Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis , 2002 .

[626]  D. Levy,et al.  Impact of high-normal blood pressure on the risk of cardiovascular disease. , 2002, The New England journal of medicine.

[627]  G. Parati,et al.  Task Force II: Blood pressure measurement and cardiovacular outcome , 2001, Blood pressure monitoring.

[628]  T. Douglas Bradley,et al.  High prevalence of unrecognized sleep apnoea in drug-resistant hypertension , 2001, Journal of hypertension.

[629]  T. Meinertz,et al.  Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.

[630]  Daniel Levy,et al.  Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study , 2001, The Lancet.

[631]  T. Pischon,et al.  Use of beta‐blockers in obesity hypertension: potential role of weight gain , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[632]  F. Magrini,et al.  High prevalence of cardiac and extracardiac target organ damage in refractory hypertension , 2001, Journal of hypertension.

[633]  G Parati,et al.  Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA) , 2001, Journal of hypertension.

[634]  S. Yusuf,et al.  Ramipril and the development of diabetes. , 2001, JAMA.

[635]  R. Klein,et al.  Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study , 2001, The Lancet.

[636]  G Parati,et al.  Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study , 2001, Journal of hypertension.

[637]  M E Safar,et al.  Improvement in Blood Pressure, Arterial Stiffness and Wave Reflections With a Very-Low-Dose Perindopril/Indapamide Combination in Hypertensive Patient: A Comparison With Atenolol , 2001, Hypertension.

[638]  J E Schwartz,et al.  Stroke Prognosis and Abnormal Nocturnal Blood Pressure Falls in Older Hypertensives , 2001, Hypertension.

[639]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[640]  H. Parving,et al.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.

[641]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[642]  MicheleBombelli,et al.  Alterations of Cardiac Structure in Patients With Isolated Office, Ambulatory, or Home Hypertension , 2001 .

[643]  Roberto Sega,et al.  Alterations of Cardiac Structure in Patients With Isolated Office, Ambulatory, or Home Hypertension: Data From the General Population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study) , 2001, Circulation.

[644]  R. Devereux,et al.  Effects of Once-Daily Angiotensin-Converting Enzyme Inhibition and Calcium Channel Blockade-Based Antihypertensive Treatment Regimens on Left Ventricular Hypertrophy and Diastolic Filling in Hypertension: The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PR , 2001, Circulation.

[645]  D. Carroll,et al.  Blood Pressure Reactions to Acute Psychological Stress and Future Blood Pressure Status: A 10-Year Follow-Up of Men in the Whitehall II Study , 2001, Psychosomatic medicine.

[646]  E. Ambrosioni.  Pharmacoeconomic challenges in disease management of hypertension. , 2001, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[647]  F. Magrini,et al.  Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination? , 2001, Italian heart journal : official journal of the Italian Federation of Cardiology.

[648]  N. Markandu,et al.  Importance of the Renin System for Determining Blood Pressure Fall With Acute Salt Restriction in Hypertensive and Normotensive Whites , 2001, Hypertension.

[649]  D. Farley,et al.  Primary Aldosteronism: Factors Associated with Normalization of Blood Pressure after Surgery , 2001, Annals of Internal Medicine.

[650]  J. Fleg,et al.  Hormone Replacement Therapy and Longitudinal Changes in Blood Pressure in Postmenopausal Women , 2001, Annals of Internal Medicine.

[651]  S. Kjeldsen,et al.  Supine and exercise systolic blood pressure predict cardiovascular death in middle-aged men , 2001, Journal of hypertension.

[652]  J. Cramer,et al.  A systematic review of the associations between dose regimens and medication compliance. , 2001, Clinical therapeutics.

[653]  S. Yusuf,et al.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. , 2001, JAMA.

[654]  R. D'Agostino,et al.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.

[655]  F. Grodstein,et al.  Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study: A Prospective, Observational Study , 2001, Annals of Internal Medicine.

[656]  H. Parving,et al.  Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients. , 2001, Kidney international.

[657]  A. Simon,et al.  Differential Effects of Nifedipine and Co-Amilozide on the Progression of Early Carotid Wall Changes , 2001, Circulation.

[658]  Keith C. Norris,et al.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. , 2001, JAMA.

[659]  A. Zanchetti,et al.  Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study , 2001 .

[660]  C. Held,et al.  Regression of left ventricular hypertrophy in human hypertension with irbesartan , 2001, Journal of hypertension.

[661]  R. Fagard.  Exercise characteristics and the blood pressure response to dynamic physical training. , 2001, Medicine and science in sports and exercise.

[662]  W. Kirch,et al.  The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction , 2001, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[663]  W. Hiatt,et al.  Medical treatment of peripheral arterial disease and claudication. , 2001, The New England journal of medicine.

[664]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[665]  E. Schiffrin,et al.  Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension , 2001, Journal of hypertension.

[666]  L. Guize,et al.  Cardiovascular Mortality in Hypertensive Men According to Presence of Associated Risk Factors , 2001, Hypertension.

[667]  P. Ducimetiere,et al.  Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients , 2001, Hypertension.

[668]  S. Yusuf,et al.  Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial , 2001, Annals of Internal Medicine.

[669]  G. Berglund,et al.  Low-Dose Metoprolol CR/XL and Fluvastatin Slow Progression of Carotid Intima-Media Thickness: Main Results From the &bgr;-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS) , 2001, Circulation.

[670]  P. Ridker,et al.  High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. , 2001, Circulation.

[671]  J. Ménard,et al.  Risk assessment and treatment benefit in intensively treated hypertensive patients of the Hypertension Optimal Treatment (HOT) study , 2001, Journal of hypertension.

[672]  J. Gardin,et al.  Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. , 2001, Journal of the American College of Cardiology.

[673]  E. Porteri,et al.  Structural Alterations in Subcutaneous Small Arteries of Normotensive and Hypertensive Patients With Non–Insulin-Dependent Diabetes Mellitus , 2001, Circulation.

[674]  G Parati,et al.  Blood pressure measuring devices: recommendations of the European Society of Hypertension , 2001, BMJ : British Medical Journal.

[675]  R. MacInnis,et al.  ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension. , 2001, American journal of hypertension.

[676]  J. Staessen,et al.  Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension , 2001, Journal of hypertension.

[677]  P. Ghahramani,et al.  Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials , 2001, Heart.

[678]  Ali G. Gharavi,et al.  Molecular Mechanisms of Human Hypertension , 2001, Cell.

[679]  S. Yusuf,et al.  Effects of Ramipril and Vitamin E on Atherosclerosis: The Study to Evaluate Carotid Ultrasound Changes in Patients Treated With Ramipril and Vitamin E (SECURE) , 2001, Circulation.

[680]  J. Blacher,et al.  Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal Failure , 2001, Circulation.

[681]  D. Henderson-smart,et al.  Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review , 2001, BMJ : British Medical Journal.

[682]  T. Pischon,et al.  Hypothesis: β-Adrenergic Receptor Blockers and Weight Gain , 2001 .

[683]  A. Zanchetti,et al.  Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. , 2001, Journal of the American Society of Nephrology : JASN.

[684]  Emanuela Falaschetti,et al.  Association Between Smoking and Blood Pressure: Evidence From the Health Survey for England , 2001, Hypertension.

[685]  F. Luft.  Twins in Cardiovascular Genetic Research , 2001, Hypertension.

[686]  J. Higgins,et al.  Blood-pressure measurement and classification in pregnancy , 2001, The Lancet.

[687]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet , 2001 .

[688]  N. Milas,et al.  Long-Term Weight Loss and Changes in Blood Pressure: Results of the Trials of Hypertension Prevention, Phase II , 2001, Annals of Internal Medicine.

[689]  O. Melander.  Genetic Factors in Hypertension – What is Known and What Does It Mean? , 2001, Blood pressure.

[690]  H. Crijns,et al.  Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial , 1999, Journal of hypertension.

[691]  K. Wink.  Are Beta-Blockers Efficacious as First-Line Therapy for Hypertension in the Elderly? , 2001 .

[692]  R. Asmar,et al.  Effect of Antihypertensive Agents on Arterial Stiffness as Evaluated by Pulse Wave Velocity , 2001, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[693]  E Picano,et al.  Diagnosis of myocardial ischemia in hypertensive patients. , 2001, Journal of hypertension.

[694]  T. Pischon,et al.  Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis. , 2001, Hypertension.

[695]  B Neal,et al.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials , 2000, The Lancet.

[696]  M. Cooper,et al.  Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study , 2000, BMJ : British Medical Journal.

[697]  P. Choyke,et al.  Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. , 2000, The Journal of clinical endocrinology and metabolism.

[698]  J W Erdman,et al.  AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. , 2000, Stroke.

[699]  A. Zanchetti,et al.  Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy , 2000, Journal of hypertension.

[700]  L. Bang,et al.  Do we undertreat hypertensive smokers? A comparison between smoking and non-smoking hypertensives , 2000, Blood pressure monitoring.

[701]  A. Rocchini.  Obesity hypertension, salt sensitivity and insulin resistance. , 2000, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[702]  P. Gosse,et al.  Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study , 2000, Journal of hypertension.

[703]  B. Sibai,et al.  Should the definition of preeclampsia include a rise in diastolic blood pressure of >/=15 mm Hg to a level <90 mm Hg in association with proteinuria? , 2000, American journal of obstetrics and gynecology.

[704]  G. Mancia,et al.  Adrenergic and Reflex Abnormalities in Obesity-Related Hypertension , 2000, Hypertension.

[705]  Michael E. Miller,et al.  Effect of Amlodipine on the Progression of Atherosclerosis and the Occurrence of Clinical Events , 2000, Circulation.

[706]  B. Conrad,et al.  Relationship Between Circadian Blood Pressure Patterns and Progression of Early Carotid Atherosclerosis: A 3-Year Follow-Up Study , 2000, Circulation.

[707]  C. Bulpitt,et al.  Response to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic Hypertension , 2000, Circulation.

[708]  John S Yudkin,et al.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study , 2000, BMJ : British Medical Journal.

[709]  John S. Scott,et al.  Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of Atherosclerosis with Ramipril. , 2000, Journal of the American College of Cardiology.

[710]  Giuseppe Mancia,et al.  Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) , 2000, The Lancet.

[711]  Thomas Hedner,et al.  Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study , 2000, The Lancet.

[712]  P. D. de Leeuw,et al.  Sleep apnoea and hypertension , 2000, BMJ : British Medical Journal.

[713]  S. Johnston,et al.  Ischemic stroke risk with oral contraceptives: A meta-analysis. , 2000, JAMA.

[714]  S. Laurent,et al.  Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment. , 2000, Circulation.

[715]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[716]  Bertram Pitt,et al.  Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II , 2000, The Lancet.

[717]  D. Cook,et al.  Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. , 2000, Archives of internal medicine.

[718]  P. Krijnen,et al.  The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. , 2000, The New England journal of medicine.

[719]  R. Schrier,et al.  Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. , 2000, Diabetes care.

[720]  M. Schroll,et al.  Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. , 2000, Hypertension.

[721]  F. Nieto,et al.  Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus , 2000 .

[722]  D. Reda,et al.  Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. , 2000, Archives of internal medicine.

[723]  Eduard Diogène,et al.  β-Adrenergic Blocking Agents in Heart Failure: Benefits of Vasodilating and Nonvasodilating Agents According to Patients' Characteristics: A Meta-analysis of Clinical Trials , 2000 .

[724]  Karla Kerlikowske,et al.  Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials , 2000, The Lancet.

[725]  S. F. Olsen,et al.  Randomised clinical trials of fish oil supplementation in high risk pregnancies , 2000, BJOG : an international journal of obstetrics and gynaecology.

[726]  P. Ducimetiere,et al.  A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. , 2000, Journal of the American College of Cardiology.

[727]  Peretz Lavie,et al.  Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study , 2000, BMJ : British Medical Journal.

[728]  G Koren,et al.  Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis , 2000, The Lancet.

[729]  R H Fagard,et al.  Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. , 1999, Archives of internal medicine.

[730]  J R Hughes,et al.  Antidepressants for smoking cessation. , 2007, The Cochrane database of systematic reviews.

[731]  W. Kannel,et al.  Risk stratification in hypertension: new insights from the Framingham Study. , 2000, American journal of hypertension.

[732]  M. de Swiet.  Maternal blood pressure and birthweight. , 2000, Lancet.

[733]  Illiam,et al.  THE EFFECT OF NISOLDIPINE AS COMPARED WITH ENALAPRIL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES AND HYPERTENSION , 2000 .

[734]  Teven,et al.  MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .

[735]  Eary,et al.  CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .

[736]  K. McDonald,et al.  Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. , 2000, JAMA.

[737]  E. Rimm,et al.  Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors , 1999, BMJ.

[738]  D. Levy,et al.  Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. , 1999, Kidney international.

[739]  S S Franklin,et al.  Ageing and hypertension: the assessment of blood pressure indices in predicting coronary heart disease. , 1999, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[740]  T Penzel,et al.  Sleep-related breathing disorder is an independent risk factor for systemic hypertension. , 1999, American journal of respiratory and critical care medicine.

[741]  R. Klein,et al.  Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. , 1999, Ophthalmology.

[742]  T. Hedner,et al.  Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study , 1999, The Lancet.

[743]  G. Beck,et al.  Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. , 1999, Journal of the American Society of Nephrology : JASN.

[744]  N. Markandu,et al.  Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. , 1999, Hypertension.

[745]  W. Cushman,et al.  The role of diastolic blood pressure when treating isolated systolic hypertension. , 1999, Archives of internal medicine.

[746]  M. A. Sellers,et al.  Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). , 1999, Journal of the American College of Cardiology.

[747]  Gianfranco Parati,et al.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. , 1999 .

[748]  G Mancia,et al.  Fluctuations of radial artery distensibility throughout the menstrual cycle. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[749]  D. Rattner.  Inguinal herniorrhaphy: for surgical specialists only? , 1999, The Lancet.

[750]  A. Bignamini,et al.  Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation. , 1999, American journal of hypertension.

[751]  M. Burnier,et al.  Compliance with antihypertensive therapy. , 1999, Clinical and experimental hypertension.

[752]  P. Whelton,et al.  Effect of dietary fiber and protein intake on blood pressure: a review of epidemiologic evidence. , 1999, Clinical and experimental hypertension.

[753]  M. J. Ashby,et al.  Optimisation of antihypertensive treatment by crossover rotation of four major classes , 1999, The Lancet.

[754]  M. Thorogood,et al.  Oral contraceptives and myocardial infarction: results of the MICA case-control study , 1999, BMJ.

[755]  G. Lip,et al.  Atenolol and fetal growth in pregnancies complicated by hypertension. , 1999, American journal of hypertension.

[756]  K. McDonald,et al.  Meta-analysis of Trials Comparing β-Blockers, Calcium Antagonists, and Nitrates for Stable Angina , 1999 .

[757]  L. Magee,et al.  Fortnightly review: management of hypertension in pregnancy. , 1999, BMJ.

[758]  G. Eknoyan,et al.  Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[759]  M. Alderman,et al.  Diabetes and cardiovascular events in hypertensive patients. , 1999, Hypertension.

[760]  Jagmeet P. Singh,et al.  Blood pressure response during treadmill testing as a risk factor for new-onset hypertension. The Framingham heart study. , 1999, Circulation.

[761]  M. Pfeffer,et al.  Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. , 1999, Journal of the American College of Cardiology.

[762]  Karla Kerlikowske,et al.  Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials , 1999, The Lancet.

[763]  C. Bulpitt,et al.  Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension , 1999 .

[764]  L. Bouter,et al.  Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[765]  L. Niskanen,et al.  Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial , 1999, The Lancet.

[766]  N Freemantle,et al.  beta Blockade after myocardial infarction: systematic review and meta regression analysis. , 1999, BMJ.

[767]  G. Guyatt,et al.  The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. , 1999, American journal of hypertension.

[768]  L Guize,et al.  Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. , 1999, Hypertension.

[769]  J. Halimi,et al.  Renal characteristics and effect of angiotensin suppression in oral contraceptive users. , 1999, Hypertension.

[770]  F. Luft,et al.  Molecular genetics of human hypertension. , 1998, Current opinion in cardiology.

[771]  J A Staessen,et al.  Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension , 1998, Journal of hypertension.

[772]  D. Vaughan,et al.  Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. , 1998, Hypertension.

[773]  R. Senior,et al.  Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. , 1998, Circulation.

[774]  A. Zanchetti,et al.  The Verapamil in Hypertension and Atherosclerosis Study (VHAS): Results of long‐term randomized treatment with either verapamil or chlorthalidone on carotid intima‐media thickness , 1998, Journal of hypertension.

[775]  Roberto Sega,et al.  Seasonal variations in home and ambulatory blood pressure in the PAMELA population , 1998 .

[776]  G. Parati,et al.  The smoothness index: A new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension , 1998, Journal of hypertension.

[777]  J. Tuomilehto,et al.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.

[778]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[779]  G. Mancia,et al.  Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. , 1998, Blood pressure.

[780]  T. Mori,et al.  Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives. , 1998, Hypertension.

[781]  S. Jacob,et al.  Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents? , 1998, American journal of hypertension.

[782]  R. Bigazzi,et al.  Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension , 1998, Journal of hypertension.

[783]  S Hulley,et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.

[784]  K Nagai,et al.  Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama Study. , 1998, Hypertension.

[785]  Gruppo di Studio Ipertensione in Gravidanza.  Nifedipine versus expectant management in mild to moderate hypertension in pregnancy , 1998, British journal of obstetrics and gynaecology.

[786]  Shigeru Hisamichi,et al.  Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population‐based observation in Ohasama, Japan , 1998, Journal of hypertension.

[787]  U. Goldbourt,et al.  Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?: A Systematic Review , 1998 .

[788]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[789]  J. Cutler,et al.  Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure. , 1998, Archives of internal medicine.

[790]  G. Parati,et al.  Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study , 1998, Journal of hypertension.

[791]  N. Graudal,et al.  Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. , 1998, JAMA.

[792]  J. Webster,et al.  Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis , 1998, Journal of Human Hypertension.

[793]  W. Elliott,et al.  Circadian variation in the timing of stroke onset: a meta-analysis. , 1998, Stroke.

[794]  G. Parati,et al.  Difference between clinic and daytime blood pressure is not a measure of the white coat effect. , 1998, Hypertension.

[795]  L. Køber,et al.  Long-term prognosis after acute myocardial infarction in patients with a history of arterial hypertension , 1998 .

[796]  P. Whelton,et al.  Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. , 1998, JAMA.

[797]  R. Schrier,et al.  The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. , 1998, The New England journal of medicine.

[798]  David R. Jones,et al.  Automated, ambulatory, or conventional blood pressure measurement in pregnancy: Which is the better predictor of severe hypertension? ☆ ☆☆ ★ ★★ , 1998 .

[799]  Beverley Balkau,et al.  High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study , 1998, Diabetes Care.

[800]  P. Palatini.  Exaggerated blood pressure response to exercise: pathophysiologic mechanisms and clinical relevance. , 1998, The Journal of sports medicine and physical fitness.

[801]  Pierre-François Plouin,et al.  Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. , 1998, Hypertension.

[802]  L. Hansson,et al.  Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. , 1998, Hypertension.

[803]  R H Selzer,et al.  The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events , 1998, Annals of Internal Medicine.

[804]  L. Ruilope,et al.  Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. , 1998, Hypertension.

[805]  F. Speizer,et al.  Body Weight, Weight Change, and Risk for Hypertension in Women , 1998, Annals of Internal Medicine.

[806]  D. Taylor,et al.  Automated, ambulatory, or conventional blood pressure measurement in pregnancy: which is the better predictor of severe hypertension? , 1997, American journal of obstetrics and gynecology.

[807]  J. Staessen,et al.  Should exercise blood pressure be measured in clinical practice? , 1998, Journal of hypertension.

[808]  J. Hopper,et al.  Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women. , 1998, Annals of epidemiology.

[809]  P. Thürmann,et al.  Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension. , 1998, Circulation.

[810]  M. Winniford,et al.  Cigarette smoking increases sympathetic outflow in humans. , 1998, Circulation.

[811]  G Mancia,et al.  Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. , 1998, Hypertension.

[812]  S. Pocock,et al.  Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators. , 1997, Stroke.

[813]  L Guize,et al.  Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. , 1997, Hypertension.

[814]  J. Staessen,et al.  Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy , 1997, Journal of hypertension.

[815]  E Casiglia,et al.  Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. , 1997, Hypertension.

[816]  N J Wald,et al.  Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence , 1997, BMJ.

[817]  K. Kugiyama,et al.  Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. , 1997, Journal of the American College of Cardiology.

[818]  E. O’Brien,et al.  Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. , 1997, JAMA.

[819]  N. Poulter,et al.  Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994 , 1997, Journal of hypertension.

[820]  S. Rabkin,et al.  Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[821]  Jan A Staessen,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.

[822]  Arno W. Hoes,et al.  Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. , 1997, Circulation.

[823]  G. Lip,et al.  Malignant hypertension in young women is related to previous hypertension in pregnancy, not oral contraception. , 1997, QJM : monthly journal of the Association of Physicians.

[824]  G. Parati,et al.  Smoking impairs baroreflex sensitivity in humans. , 1997, The American journal of physiology.

[825]  J. Staessen,et al.  Conventional and ambulatory blood pressure and menopause in a prospective population study , 1997, Journal of Human Hypertension.

[826]  D. Levy,et al.  Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. , 1997, Circulation.

[827]  G. Mancia,et al.  Ambulatory and home blood pressure normality in the elderly: data from the PAMELA population. , 1997, Hypertension.

[828]  Y. Imai,et al.  Reproducibility of home blood pressure measurements over a 1-year period. , 1997, American journal of hypertension.

[829]  F. Magrini,et al.  Echocardiographic patterns of myocardial fibrosis in hypertensive patients: endomyocardial biopsy versus ultrasonic tissue characterization. , 1997, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[830]  G. Jennings.  Exercise and blood pressure: Walk, run or swim? , 1997, Journal of hypertension.

[831]  R. Kronmal,et al.  Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. , 1997, Stroke.

[832]  J. Cutler,et al.  Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men , 1997, Annals of Internal Medicine.

[833]  Law Mr.  Epidemiologic evidence on salt and blood pressure. , 1997 .

[834]  W. Knowler,et al.  Glucose tolerance and mortality, including a substudy of tolbutamide treatment , 1997, Diabetologia.

[835]  P. Whelton,et al.  End-stage renal disease in African-American and white men. 16-year MRFIT findings. , 1997, JAMA.

[836]  A C Shore,et al.  Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. , 1997, The Journal of clinical investigation.

[837]  I. Puddey,et al.  Alcohol, hypertension and the cardiovascular system: a critical appraisal , 1997, Addiction biology.

[838]  C. H. Chen,et al.  Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. , 1997, Circulation.

[839]  Giuseppe Mancia,et al.  Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular Hypertrophy , 1997 .

[840]  S. Kjeldsen,et al.  Predictors of 7‐year changes in exercise blood pressure: effects of smoking, physical fitness and pulmonary function , 1997, Journal of hypertension.

[841]  G. Mancia,et al.  Baroreflex impairment by low sodium diet in mild or moderate essential hypertension. , 1997, Hypertension.

[842]  J. Cutler,et al.  Randomized trials of sodium reduction: an overview. , 1997, The American journal of clinical nutrition.

[843]  I. Perry,et al.  Ambulatory blood pressure in pregnancy and fetal growth , 1997, The Lancet.

[844]  G. Jensen,et al.  Treatment of renovascular hypertension. , 1997, Nephron.

[845]  P. Gorelick,et al.  Status of lipids as a risk factor for stroke. , 1997, Neuroepidemiology.

[846]  R H Fagard,et al.  Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. , 1997, Hypertension.

[847]  K. Zarnke,et al.  A randomized study comparing a patient-directed hypertension management strategy with usual office-based care. , 1997, American journal of hypertension.

[848]  M. Law.  Epidemiologic evidence on salt and blood pressure. , 1997, American journal of hypertension.

[849]  B. Davis,et al.  Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. , 1996, JAMA.

[850]  J F Toole,et al.  Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. , 1996, Stroke.

[851]  S. Haffner,et al.  Effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans. The San Antonio Heart Study. , 1996, American journal of epidemiology.

[852]  H. Parving.  Initiation and progression of diabetic nephropathy. , 1996, The New England journal of medicine.

[853]  P. Schollmeyer,et al.  Diagnosis of renovascular disease by intra- and extrarenal Doppler scanning. , 1996, Kidney international.

[854]  M. Rocco,et al.  Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. , 1996, JAMA.

[855]  G. Mancia,et al.  White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next? , 1996, Journal of hypertension.

[856]  M. Chesney,et al.  Lack of independent relationships between left ventricular mass and cardiovascular reactivity to physical and psychological stress in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. , 1996, American journal of hypertension.

[857]  M. Schulzer,et al.  'Unqualified success' and 'unmitigated failure': number-needed-to-treat-related concepts for assessing treatment efficacy in the presence of treatment-induced adverse events. , 1996, International journal of epidemiology.

[858]  J. Manson,et al.  Prospective study of oral contraceptives and hypertension among women in the United States. , 1996, Circulation.

[859]  L. Fried,et al.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. , 1996, Stroke.

[860]  J. Staessen,et al.  Prognostic value of invasive hemodynamic measurements at rest and during exercise in hypertensive men. , 1996, Hypertension.

[861]  S. Daniels,et al.  Correlates of the hemodynamic determinants of blood pressure. , 1996, Hypertension.

[862]  G. Mancia,et al.  Benefits and cost-effectiveness of antihypertensive therapy. The actuarial versus the intervention trial approach. , 1996, Journal of hypertension.

[863]  E. Casiglia,et al.  Lack of influence of menopause on blood pressure and cardiovascular risk profile: a 16-year longitudinal study concerning a cohort of 568 women , 1996, Journal of hypertension.

[864]  S. Wannamethee,et al.  Patterns of alcohol intake and risk of stroke in middle-aged British men. , 1996, Stroke.

[865]  T. Ohkubo,et al.  Predictive power of screening blood pressure, ambulatory blood pressure and blood pressure measured at home for overall and cardiovascular mortality: a prospective observation in a cohort from Ohasama, northern Japan. , 1996, Blood pressure monitoring.

[866]  W. Kannel.  Blood pressure as a cardiovascular risk factor: prevention and treatment. , 1996, JAMA.

[867]  R. Vasan,et al.  The progression from hypertension to congestive heart failure. , 1996, JAMA.

[868]  J. Staessen,et al.  Prediction of the actual awake and asleep blood pressures by various methods of 24 h pressure analysis , 1996, Journal of hypertension.

[869]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[870]  I. Deary,et al.  The Effects of Antihypertensive Treatment on Cognitive Function: Results from the HOPE Study , 1996, Journal of the American Geriatrics Society.

[871]  P. Hamet,et al.  Shanghai trial of nifedipine in the elderly (STONE). , 1996, Journal of hypertension.

[872]  M. Prince,et al.  Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults , 1996, BMJ.

[873]  T. Hedner,et al.  Smoking affects blood pressure. , 1996, Blood pressure.

[874]  Sacchi,et al.  Prognostic significance of blood pressure variability in essential hypertension. , 1996, Blood pressure monitoring.

[875]  A. Halligan,et al.  Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry , 1996, The Lancet.

[876]  J. Laragh,et al.  Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. , 1996, Circulation.

[877]  R. Rogers,et al.  Obstructive sleep apnea. , 1996, The New England journal of medicine.

[878]  P. Whelton,et al.  Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.

[879]  J. Redón,et al.  Microalbuminuria, left ventricular mass and ambulatory blood pressure in essential hypertension. , 1995, Kidney international. Supplement.

[880]  R. Havlik,et al.  The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. , 1995, JAMA.

[881]  G. Mancia,et al.  Ambulatory blood pressure normality: results from the PAMELA study , 1995, Journal of hypertension.

[882]  J. Staessen,et al.  Heritability of conventional and ambulatory blood pressures. A study in twins. , 1995, Hypertension.

[883]  C. Pepine,et al.  Circadian variation in coronary tone in patients with stable angina. Protective role of the endothelium. , 1995, Circulation.

[884]  G. Schillaci,et al.  Cigarette smoking, ambulatory blood pressure and cardiac hypertrophy in essential hypertension , 1995, Journal of hypertension.

[885]  A. Hofman,et al.  Diuretics, -Blockers, and the Risk for Sudden Cardiac Death in Hypertensive Patients , 1995, Annals of Internal Medicine.

[886]  D. Rizzoni,et al.  Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment , 1995, Journal of hypertension.

[887]  D G Beevers,et al.  Complications and survival of 315 patients with malignant-phase hypertension , 1995, Journal of hypertension.

[888]  F. Fuchs,et al.  Study of the usefulness of optic fundi examination of patients with hypertension in a clinical setting. , 1995, Journal of human hypertension.

[889]  P Whelton,et al.  Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. , 1995, Hypertension.

[890]  G Parati,et al.  Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large data base. , 1995, Blood pressure.

[891]  G. Reboldi,et al.  Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. , 1995, Journal of the American College of Cardiology.

[892]  G. Parati,et al.  Lack of placebo effect on ambulatory blood pressure. , 1995, American journal of hypertension.

[893]  D. Reda,et al.  Department of veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. , 1995, American journal of hypertension.

[894]  Susan R. Johnson,et al.  Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial , 1995 .

[895]  J. Staessen,et al.  Relation of left ventricular mass and filling to exercise blood pressure and rest blood pressure. , 1995, The American journal of cardiology.

[896]  G. Reboldi,et al.  Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. , 1994, Hypertension.

[897]  M. Beevers,et al.  The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England , 1994, Journal of hypertension.

[898]  R Doll,et al.  Mortality in relation to smoking: 40 years' observations on male British doctors , 1994, BMJ.

[899]  P. Poole‐Wilson,et al.  Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. , 1994, European heart journal.

[900]  D. Levy,et al.  Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. , 1994, Circulation.

[901]  G. Mancia,et al.  Mechanisms Responsible for Sympathetic Activation by Cigarette Smoking in Humans , 1994, Circulation.

[902]  E. Bravo,et al.  Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. , 1994, Endocrine reviews.

[903]  G. Parati,et al.  Increase in blood pressure reproducibility by repeated semi‐automatic blood pressure measurements in the clinic environment , 1994, Journal of hypertension.

[904]  M. Stowasser,et al.  HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSION , 1994, Clinical and experimental pharmacology & physiology.

[905]  J. Gardin,et al.  Exercise blood pressure response and 5-year risk of elevated blood pressure in a cohort of young adults: the CARDIA study. , 1994, American journal of hypertension.

[906]  D. Mant,et al.  Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation , 1994, The Lancet.

[907]  H. Bjørnstad,et al.  Left Ventricular Mass and Cardiovascular Reactivity in Young Men , 1994, Hypertension.

[908]  G. Beck,et al.  The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. , 1994, The New England journal of medicine.

[909]  R. Collins,et al.  Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. , 1994, British medical bulletin.

[910]  G. Leonetti.  Effects of Cilazapril and Nitrendipine on Blood Pressure, Mood, Sleep, and Cognitive Function in Elderly Hypertensive Patients: An Italian Multicenter Study , 1994, Journal of cardiovascular pharmacology.

[911]  A Fournier,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.

[912]  Li-sheng Liu,et al.  Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database , 1994, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[913]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[914]  L. Ruilope,et al.  Clinical relevance of proteinuria and microalbuminuria. , 1993, Current opinion in nephrology and hypertension.

[915]  G Mancia,et al.  Prognostic value of 24-hour blood pressure variability , 1993, Journal of hypertension.

[916]  M. Mulvany,et al.  Histology of subcutaneous small arteries from patients with essential hypertension. , 1993, Hypertension.

[917]  F. Sacks,et al.  Does Fish Oil Lower Blood Pressure? A Meta‐Analysis of Controlled Trials , 1993, Circulation.

[918]  L. Kuller,et al.  Decreased ankle/arm blood pressure index and mortality in elderly women. , 1993, JAMA.

[919]  P. Whelton,et al.  Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. , 1993, Archives of internal medicine.

[920]  H. Adami,et al.  Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden. , 1993, Archives of internal medicine.

[921]  L. Kuller,et al.  The Relationship between Ankle‐Arm Index and Mortality in Older Men and Women , 1993, Journal of the American Geriatrics Society.

[922]  N. Cook,et al.  Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group. , 1993, Archives of internal medicine.

[923]  J. D. Proctor,et al.  Effect of hydrochlorothiazide, enalapril, and propranolol on quality of life and cognitive and motor function in hypertensive patients. , 1993, Clinical pharmacy.

[924]  J. Salonen,et al.  Ultrasound B-mode imaging in observational studies of atherosclerotic progression. , 1993, Circulation.

[925]  K Rodahl,et al.  Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. , 1993, The New England journal of medicine.

[926]  E. Lakatta.  Deficient Neuroendocrine Regulation of the Cardiovascular System With Advancing Age in Healthy Humans , 1993, Circulation.

[927]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[928]  J. Madans,et al.  Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. , 1993, Archives of internal medicine.

[929]  R. Kirkpatrick,et al.  Ambulatory Blood Pressure Monitoring , 1993, The Journal of the American Board of Family Medicine.

[930]  G. Parati,et al.  Limited reproducibility of hourly blood pressure values obtained by ambulatory blood pressure monitoring: implications for studies on antihypertensive drugs , 1992, Journal of hypertension.

[931]  P Ducimetière,et al.  Prognostic significance of exercise blood pressure and heart rate in middle-aged men. , 1992, Hypertension.

[932]  S. Willich,et al.  Increased onset of sudden cardiac death in the first three hours after awakening. , 1992, The American journal of cardiology.

[933]  R. J. Sjoberg,et al.  The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls. , 1992, Archives of internal medicine.

[934]  J. Manson,et al.  The primary prevention of myocardial infarction. , 1992, The New England journal of medicine.

[935]  G. Parati,et al.  Persistent blood pressure increase induced by heavy smoking. , 1992, Journal of hypertension.

[936]  P. Sleight,et al.  The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension , 1992, Journal of hypertension.

[937]  R. Langer,et al.  Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.

[938]  D. Levy,et al.  Is There a Relationship between Exercise Systolic Blood Pressure Response and Left Ventricular Mass? , 1992, Annals of Internal Medicine.

[939]  V. Froelicher,et al.  Impact of left ventricular hypertrophy on blood pressure responses to exercise. , 1992, The American journal of cardiology.

[940]  J. Fleiss,et al.  Frequency Domain Measures of Heart Period Variability and Mortality After Myocardial Infarction , 1992, Circulation.

[941]  W. White,et al.  Blood pressure load and target organ effects in patients with essential hypertension. , 1991, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[942]  B. Dahlöf,et al.  Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) , 1991, The Lancet.

[943]  H. Black,et al.  Resistant hypertension in a tertiary care clinic. , 1991, Archives of internal medicine.

[944]  K. Radack,et al.  Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. , 1991, Archives of internal medicine.

[945]  A. Zanchetti,et al.  Functional role of renal afferents. , 1991, Physiological reviews.

[946]  H. Köhler,et al.  Acanthocyturia--a characteristic marker for glomerular bleeding. , 1991, Kidney international.

[947]  J. Stamler,et al.  Epidemiologic findings on body mass and blood pressure in adults. , 1991, Annals of epidemiology.

[948]  T. Pickering,et al.  Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study. , 1991, JAMA.

[949]  J. Laragh,et al.  Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. , 1991, The New England journal of medicine.

[950]  P. Wilson,et al.  The epidemiology of impaired glucose tolerance and hypertension. , 1991, American heart journal.

[951]  L. Kuller,et al.  The ratio of ankle and arm arterial pressure as an independent predictor of mortality. , 1991, Atherosclerosis.

[952]  L. Goldman,et al.  Expected Gains in Life Expectancy From Various Coronary Heart Disease Risk Factor Modifications , 1991, Circulation.

[953]  J. Staessen,et al.  Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies. , 1991, The American journal of cardiology.

[954]  J. Laragh,et al.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. , 1991, Annals of internal medicine.

[955]  G. Parati,et al.  Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment. , 1991, Journal of hypertension.

[956]  I. Macgillivray,et al.  Recording diastolic blood pressure in pregnancy. , 1991, BMJ.

[957]  L. Goldman,et al.  Erratum: Expected gains in life expectancy from various coronary heart disease risk factor modifications (Circulation 1991;83:1194-1201) , 1991 .

[958]  J. Staessen,et al.  Exercise blood pressure and target organ damage in essential hypertension. , 1991, Journal of human hypertension.

[959]  G. Parati,et al.  Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition. , 1990, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[960]  K. Pennert,et al.  The J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the Primary Prevention Trial in Gothenburg, Sweden. , 1990, Journal of hypertension.

[961]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[962]  B. Sibai,et al.  A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. , 1990, American journal of obstetrics and gynecology.

[963]  T. J. White,et al.  Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study. , 1990, Hypertension.

[964]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[965]  G. Schillaci,et al.  Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. , 1990, Circulation.

[966]  D E Manyari,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[967]  A. Stulting,et al.  Ophthalmoscopy versus non-mydriatic fundus photography in the detection of diabetic retinopathy in black patients. , 1990, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[968]  L. Korkmaz,et al.  Circadian variation in circulating platelet aggregates. , 1989, Annals of medicine.

[969]  B. Maharaj.  Calcium channel blockers in hypertension. , 1989, International journal of cardiology.

[970]  C. Bulpitt,et al.  Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly. , 1989, BMJ.

[971]  W. A. Littler,et al.  USEFULNESS OF OPHTHALMOSCOPY IN MILD TO MODERATE HYPERTENSION , 1989, The Lancet.

[972]  L Guize,et al.  Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. , 1989, Hypertension.

[973]  G. Jennings,et al.  Regional norepinephrine turnover in human hypertension. , 1989, Clinical and experimental hypertension. Part A, Theory and practice.

[974]  A. Hofman,et al.  Importance of body weight in determining rise and level of blood pressure in postmenopausal women. , 1988 .

[975]  A. Hofman,et al.  Importance of body weight in determining rise and level of blood pressure in postmenopausal women , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[976]  G. Assmann,et al.  The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. , 1988, American heart journal.

[977]  E. O’Brien,et al.  DIPPERS AND NON-DIPPERS , 1988, The Lancet.

[978]  W. Willett,et al.  A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. , 1988, The New England journal of medicine.

[979]  G. Friedman,et al.  Precursors of essential hypertension: body weight, alcohol and salt use, and parental history of hypertension. , 1988, Preventive medicine.

[980]  J. Laragh,et al.  How common is white coat hypertension? , 1988, JAMA.

[981]  K. Pennert,et al.  Low Mortality from All Causes, Including Myocardial Infarction, in Well‐Controlled Hypertensives Treated with a Beta‐Blocker Plus Other Antihypertensives , 1987, Journal of hypertension.

[982]  H. Black,et al.  Thallium-201 stress imaging in hypertensive patients. , 1987, Hypertension.

[983]  R S Paffenbarger,et al.  Heart rate and cardiovascular mortality: the Framingham Study. , 1987, American heart journal.

[984]  P. Wilson,et al.  Coronary risk prediction in adults (the Framingham Heart Study) , 1987, The American journal of cardiology.

[985]  R. Vandongen,et al.  REGULAR ALCOHOL USE RAISES BLOOD PRESSURE IN TREATED HYPERTENSIVE SUBJECTS A Randomised Controlled Trial , 1987, The Lancet.

[986]  J. Miller,et al.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. , 1987, The American journal of cardiology.

[987]  G Parati,et al.  Alerting reaction and rise in blood pressure during measurement by physician and nurse. , 1987, Hypertension.

[988]  E F Cook,et al.  Circadian variation of transient myocardial ischemia in patients with coronary artery disease. , 1987, Circulation.

[989]  J. Haze,et al.  Obstructive sleep apnea. , 1987, Cranio : the journal of craniomandibular practice.

[990]  R. Vandongen,et al.  Vegetarian diet in mild hypertension: a randomised controlled trial. , 1986, British medical journal.

[991]  U. Adamson,et al.  Plasma aldosterone-plasma renin activity ratio. A simple test to identify patients with primary aldosteronism. , 1986, Acta endocrinologica.

[992]  K. Svärdsudd,et al.  Age-related changes in blood pressure. , 1986, Hypertension.

[993]  T S Warrender,et al.  Randomised trial of treatment of hypertension in elderly patients in primary care. , 1986, British medical journal.

[994]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[995]  J. Ockene.  Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. , 1986, Preventive medicine.

[996]  S C Hunt,et al.  A comparison of positive family history definitions for defining risk of future disease. , 1986, Journal of chronic diseases.

[997]  S. Shapiro,et al.  The risk of myocardial infarction after quitting smoking in men under 55 years of age. , 1985, The New England journal of medicine.

[998]  G. Murray,et al.  Factors influencing mortality in malignant hypertension. , 1985, Journal of Hypertension - Supplement.

[999]  E. Braunwald,et al.  Circadian variation in the frequency of onset of acute myocardial infarction. , 1985, The New England journal of medicine.

[1000]  G. Parati,et al.  Lack of alerting reactions to intermittent cuff inflations during noninvasive blood pressure monitoring. , 1985, Hypertension.

[1001]  C. Bulpitt,et al.  Mortality and Morbidity Results from the European Working Party on High Blood Pressure in the Elderly Trial , 1985, The Lancet.

[1002]  M. Blaufox,et al.  Dietary therapy slows the return of hypertension after stopping prolonged medication. , 1985, JAMA.

[1003]  S. M. Collins,et al.  Ultrasonic backscatter and collagen in normal ventricular myocardium. , 1984, Circulation.

[1004]  Giuseppe Mancia,et al.  EFFECTS OF BLOOD-PRESSURE MEASUREMENT BY THE DOCTOR ON PATIENT'S BLOOD PRESSURE AND HEART RATE , 1983, The Lancet.

[1005]  A Pedotti,et al.  Blood Pressure and Heart Rate Variabilities in Normotensive and Hypertensive Human Beings , 1983, Circulation research.

[1006]  S. Textor,et al.  The changing clinical spectrum of primary aldosteronism. , 1983, The American journal of medicine.

[1007]  A Pedotti,et al.  Continuous vs intermittent blood pressure measurements in estimating 24-hour average blood pressure. , 1983, Hypertension.

[1008]  D. Andersen,et al.  Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. , 1983, Diabetes.

[1009]  J. Singh,et al.  Hypertensive retinopathy. , 1983, Indian journal of ophthalmology.

[1010]  M. Blaufox,et al.  The effect of treatment on mortality in "mild" hypertension: results of the hypertension detection and follow-up program. , 1982, The New England journal of medicine.

[1011]  C. Mogensen.  Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy , 1982, British medical journal.

[1012]  J. Staessen,et al.  Increase in plasma aldosterone during prolonged captopril treatment. , 1982, The American journal of cardiology.

[1013]  G. Mancia,et al.  Cardiovascular regulation during sleep. , 1982, Archives italiennes de biologie.

[1014]  N. Reichek,et al.  Left Ventricular Hypertrophy: Relationship of Anatomic, Echocardiographic and Electrocardiographic Findings , 1981, Circulation.

[1015]  G. Mancia,et al.  1 – Cardiovascular Regulation during Sleep , 1982 .

[1016]  A. Helgeland.  Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. , 1980, The American journal of medicine.

[1017]  C. Bengtsson,et al.  Serum lipids, arterial blood pressure and body weight in relation to the menopause: results from a population study of women in Göteborg, Sweden. , 1980, Scandinavian journal of clinical and laboratory investigation.

[1018]  J. Oates,et al.  Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy. , 1979, The New England journal of medicine.

[1019]  E. Raftery,et al.  CIRCADIAN VARIATION OF BLOOD-PRESSURE , 1978, The Lancet.

[1020]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[1021]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[1022]  C. Seltzer.  Effect of smoking on blood pressure. , 1974, American heart journal.

[1023]  N. M. Keith,et al.  Some Different Types Of Essential Hypertension: Their Course And Prognosis , 1939, The American journal of the medical sciences.

[1024]  G. Pickering,et al.  Hypertension. Definitions, natural histories and consequences. , 1972, The American journal of medicine.

[1025]  J. McEwan.  Oral contraceptives and hypertension. , 1969, British medical journal.

[1026]  A. Masi,et al.  Cerebrovascular diseases associated with the use of oral contraceptives. A review of the English-language literature. , 1970, Annals of internal medicine.

[1027]  E. M. Symonds,et al.  Alteration by oral contraceptives of normal menstrual changes in plasma renin activity, concentration and substrate. , 1969, Clinical science.

[1028]  T. Kollevold,et al.  [Primary aldosteronism]. , 1969, Nordisk medicin.

[1029]  Clyne,et al.  Investigation of relation between use of oral contraceptives and thromboembolic disease. , 1968, British medical journal.

[1030]  W. Inman,et al.  Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age. , 1968, British medical journal.

[1031]  T. Kearns,et al.  Prognostic importance of ophthalmoscopic findings in essential hypertension. , 1966, Journal of the American Medical Association (JAMA).

[1032]  J. Conn.  Hypertension, the potassium ion and impaired carbohydrate tolerance. , 1965, The New England journal of medicine.

[1033]  J. Giese.  ACUTE HYPERTENSIVE VASCULAR DISEASE. 2. STUDIES ON VASCULAR REACTION PATTERNS AND PERMEABILITY CHANGES BY MEANS OF VITAL MICROSCOPY AND COLLOIDAL TRACER TECHNIQUE. , 1964, Acta pathologica et microbiologica Scandinavica.

[1034]  J. N. Morris,et al.  Nature of essential hypertension. , 1960, Lancet.

[1035]  G. Perera.  Hypertensive vascular disease; description and natural history. , 1955, Journal of chronic diseases.

[1036]  J. Moyer,et al.  Malignant hypertension and hypertensive encephalopathy. , 1953, The American journal of medicine.

[1037]  R. Levy,et al.  Transient tachycardia; prognostic significance alone and in association with transient hypertension. , 1945, The Medical press of Egypt.